AI Financial Corp 10-Q for FY2026 Q2
AI Financial Corp (AIFC)
About this 10-Q
AI Financial Corp filed this 10-Q on August 17, 2026, covering the quarter ended June 27, 2026 (FY2026 Q2).
Headline figures
Quarter ended June 27, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $2.41M
- down 62.2% from $6.38M a year earlier
- Net loss
- $229.56M
- compared with a net loss of $9.12M a year earlier
- Diluted EPS
- -$1.68
- compared with -$0.49 a year earlier
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
| Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
For
the quarterly period ended
or
| Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
Commission
File No.
(Exact name of registrant as specified in its charter)
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
| (Address of principal executive offices) | (Zip Code) |
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
The
| ||||
| (The Nasdaq Capital Market) |
Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2)
has been subject to such filing requirements for the past 90 days. ☒
Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to
Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit
such files). ☒
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one)
| Large accelerated filer | ☐ | Accelerated filer | ☐ | |
| ☒ | Smaller reporting company | |||
| Emerging growth company |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). ☐ Yes
As of August 12, 2026, there were outstanding shares of the registrant’s common stock, with a par value of $.
AI FINANCIAL CORPORATION
INDEX TO FORM 10-Q
| 2 |
PART I. FINANCIAL INFORMATION
ITEM 1. Condensed Consolidated Financial Statements
AI FINANCIAL CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(Dollars in thousands, except per-share amounts)
| June
27, 2026 | December
27, 2025* | |||||||
| (Unaudited) | ||||||||
| Assets | ||||||||
| Cash | $ | $ | ||||||
| Short term investment | ||||||||
| Trade and other receivables, net | ||||||||
| Digital assets receivable | ||||||||
| Prepaid expenses and other current assets | ||||||||
| Other current assets | ||||||||
| Current assets from discontinued operations | ||||||||
| Total current assets | ||||||||
| Property and equipment, net | ||||||||
| Right of use assets | ||||||||
| Intangible assets, net | ||||||||
| Cryptocurrency assets at fair value | ||||||||
| Deferred income taxes, net | ||||||||
| Goodwill | ||||||||
| Other assets from discontinued operations | ||||||||
| Total assets | $ | $ | ||||||
| Liabilities, Mezzanine Equity and Stockholders’ Equity (Deficit) | ||||||||
| Liabilities: | ||||||||
| Accounts payable | $ | $ | ||||||
| Accrued liabilities - other | ||||||||
| Digital assets payable | ||||||||
| Convertible debentures | ||||||||
| Operating lease liabilities | ||||||||
| Notes payable | ||||||||
| Current liabilities from discontinued operations | ||||||||
| Total current liabilities | ||||||||
| Notes payable | ||||||||
| Operating lease liabilities | ||||||||
| Total liabilities | ||||||||
| Commitments and contingencies (Note 15) | ||||||||
| Mezzanine equity | ||||||||
| Convertible preferred stock, series S - par value $ per share authorized, shares issued and outstanding at June 27, 2026 and December 27, 2025 | ||||||||
| Stockholders’ equity: | ||||||||
| Preferred stock, series A-1 - par value $ per share authorized, shares issued and outstanding at June 27, 2026 and December 27, 2025 | ||||||||
| Preferred stock, series B - par value $ per share, authorized, shares issued and outstanding at June 27, 2026 and December 27, 2025 | ||||||||
| Convertible preferred stock, series I - par value $ per share, authorized, and shares issued and outstanding at June 27, 2026 and December 27, 2025 | ||||||||
| Preferred stock, series M - par value $ per share, authorized, shares issued and outstanding at June 27, 2026 and December 27, 2025 | ||||||||
| Preferred stock, series Q - par value $ per share, authorized, and shares issued and outstanding at June 27, 2026 and December 27, 2025 | ||||||||
| Convertible preferred stock, series S - par value $ per share authorized, shares issued and outstanding at June 27, 2026 and December 27, 2025, respectively | ||||||||
| Convertible preferred stock, series V - par value $ per share, authorized, and shares issued and outstanding at June 27, 2026 and December 27, 2025, respectively | ||||||||
| Preferred stock,value | ||||||||
| Common stock, par value $ per share, shares authorized, and shares issued and outstanding at June 27, 2026 and at December 27, 2026, respectively | ||||||||
| Treasury stock, at cost, and shares outstanding at June 27, 2026 and December 27, 2026 | ( | ) | ||||||
| Accumulated other comprehensive loss | ( | ) | ( | ) | ||||
| Additional paid-in capital | ||||||||
| Accumulated deficit | ( | ) | ( | ) | ||||
| Equity attributable to AI Financial Corporation shareholders | ||||||||
| Noncontrolling interest | $ | $ | ||||||
| Total stockholder’s equity | ||||||||
| Total liabilities, mezzanine equity and stockholders’ equity | $ | $ | ||||||
| * |
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
| 3 |
AI FINANCIAL CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME
(UNAUDITED)
(Dollars in thousands, except per-share)
| For the Thirteen Weeks Ended | For the Twenty-Six Weeks Ended | |||||||||||||||
| June
27, 2026 | June
28, 2025 | June
27, 2026 | June
28, 2025 | |||||||||||||
| Revenues | $ | $ | $ | $ | ||||||||||||
| Cost of revenues | ||||||||||||||||
| Gross profit | ||||||||||||||||
| Operating expenses: | ||||||||||||||||
| Selling, general and administrative expenses | ||||||||||||||||
| Operating loss | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
| Other income (expense): | ||||||||||||||||
| Interest income (expense), net | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
| Unrealized gain on exchange transactions | ||||||||||||||||
| Unrealized loss on crypto-currency assets | ( | ) | ( | ) | ||||||||||||
| Realized gain (loss) on exchange transactions | ( | ) | ( | ) | ( | ) | ||||||||||
| Other income (expense), net | ( | ) | ( | ) | ||||||||||||
| Total other (expense) income, net | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
| Loss before benefit (provision) for income taxes | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
| Income tax benefit (provision) | ( | ) | ( | ) | ||||||||||||
| Net loss from continuing operations | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
| Loss from discontinued operations | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
| Income tax provision from discontinued operations | ||||||||||||||||
| Net loss from discontinued operations | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
| Net loss | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||
| Net loss per share: | ||||||||||||||||
| Net loss per share from continuing operations, basic and diluted | $ | ) | $ | ) | $ | ) | $ | ) | ||||||||
Net loss per share from discontinued operations, basic and diluted | $ | ) | $ | ) | $ | ) | $ | ) | ||||||||
| Net loss per share, basic and diluted | $ | ) | $ | ) | $ | ) | $ | ) | ||||||||
| Weighted average common shares outstanding: | ||||||||||||||||
| Basic and diluted | ||||||||||||||||
| Net loss | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||
| Effect of foreign currency translation adjustments | ( | ) | ||||||||||||||
| Total other comprehensive loss, net of tax | ( | ) | ||||||||||||||
| Comprehensive loss | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
| 4 |
AI FINANCIAL CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
(In thousands)
| June 27, 2026 | June 28, 2025 | |||||||
| For the Twenty-Six Weeks Ended | ||||||||
| June 27, 2026 | June 28, 2025 | |||||||
| OPERATING ACTIVITIES: | ||||||||
| Net loss from continuing operations | $ | ( | ) | $ | ( | ) | ||
| Adjustments to reconcile net loss to net cash provided by operating activities: | ||||||||
| Depreciation and amortization | ||||||||
| Amortization of seller note discount | ||||||||
| Unrealized gain/loss on cryptocurrency assets | ||||||||
| Amortization of ROU assets | ||||||||
| Unrealized gain on digital assets | ( | ) | ||||||
| Realized gain on digital assets | ||||||||
| Change in deferred tax liability | ( | ) | ( | ) | ||||
| Changes in assets and liabilities: | ||||||||
| Accounts receivable | ( | ) | ||||||
| Digital assets receivable | ||||||||
| Prepaid expenses and other current assets | ( | ) | ( | ) | ||||
| Accounts payable and accrued expenses | ( | ) | ||||||
| Digital assets payable | ( | ) | ( | ) | ||||
| Operating cash flows from discontinued operations | ( | ) | ||||||
| Net cash used in operating activities | ( | ) | ( | ) | ||||
| INVESTING ACTIVITIES: | ||||||||
| Purchase of treasury common shares | ( | ) | ||||||
| Cash acquired in Mswipe acquisition | ||||||||
| Investing cash flows from discontinued operations | ||||||||
| Net cash (used in) provided by investing activities | ( | ) | ||||||
| FINANCING ACTIVITIES: | ||||||||
| Purchases of short term certificates of deposits | ( | ) | ||||||
| Proceeds from return of certificate of deposits | ||||||||
| Proceeds from the issuance of notes payable | ||||||||
| Payments on notes payable | ( | ) | ( | ) | ||||
| Proceeds from warrants exercised | ||||||||
| Payments on related party notes payable | ( | ) | ||||||
| Financing cash flows from discontinued operations | ||||||||
| Net cash provided by financing activities | ||||||||
| Effect of changes in exchange rate on cash and cash equivalents | ||||||||
| (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS | ( | ) | ||||||
| CASH AND CASH EQUIVALENTS, beginning of period | ||||||||
| LESS CASH OF DISCONTINUED OPERATIONS, end of period | ||||||||
| CASH AND CASH EQUIVALENTS, end of period | $ | $ | ||||||
| Supplemental cash flow disclosures: | ||||||||
| Cash paid for interest | $ | $ | ||||||
| Noncash financing and investing activities: | ||||||||
| Common stock issued for Block Street asset acquisition | $ | $ | ||||||
| Common stock issued for consulting services | $ | $ | ||||||
| Common stock issued for the acquisition of Mswipe | $ | $ | ||||||
| Common stock warrants issued for the acquisition of Mswipe | $ | $ | ||||||
| Alyea common stock issued for the acquisition of Mswipe | $ | $ | ||||||
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
| 5 |
AI FINANCIAL CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY
(UNAUDITED)
(Dollars in thousands)
| Shares | Amount | Shares | Amount | Shares | Amount | Shares | Amount | Shares | Amount | Shares | Amount | Shares | Amount | Shares | Amount | Capital | Stock | Deficit | Deficit | Interest | Equity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Series A-1 Preferred | Series S-1 Preferred | Series B Preferred | Series I Preferred | Series M Preferred | Series Q Preferred | Series V Preferred | Common Stock | Additional Paid-in | Treasury | Accumulated | Accumulated Other Comprehensive | Noncontrolling | Total Stockholders’ | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Shares | Amount | Shares | Amount | Shares | Amount | Shares | Amount | Shares | Amount | Shares | Amount | Shares | Amount | Shares | Amount | Capital | Stock | Deficit | Deficit | Interest | Equity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Balance, December 27, 2025 | $ | $ | $ | $ | $ | $ | $ | $ | $ | $ | ( | ) | $ | ( | ) | $ | $ | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Common stock issued for Series I convertible stock converted | — | — | — | — | ( | ) | — | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Common stock issued for Series Q convertible stock converted | — | — | — | ( | ) | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Common stock issued for consulting agreement | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Common stock issued for Debenture converted | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Common stock issued in lieu of notes payable obligation | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Foreign currency adjustment | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Prior period adjustment | — | — | — | — | — | — | — | — | ( | ) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Net loss | — | — | — | — | — | — | — | — | ( | ) | ( | ) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Balance, March 28, 2026 | $ | $ | $ | $ | $ | $ | $ | ( | ) | $ | $ | $ | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Balance, March 28, 2026 | $ | $ | $ | $ | $ | $ | ( | ) | $ | $ | $ | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Treasury share buyback | — | — | — | — | — | — | — | — | ( | ) | ( | ) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ALT5 Sigma Corp common stock issued for Block Street | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Foreign currency adjustment | — | — | — | — | — | — | — | — | ( | ) | ( | ) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Net loss | — | — | — | — | — | — | — | — | ( | ) | ( | ) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Balance, June 27, 2026 | $ | $ | $ | $ | $ | $ | $ | $ | $ | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | $ | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 6 |
| Shares | Amount | Shares | Amount | Shares | Amount | Shares | Amount | Shares | Amount | Shares | Amount | Shares | Amount | Shares | Amount | Capital | Deficit | Deficit | Interest | Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Series A-1 Preferred | Series S-1 Preferred | Series B Preferred | Series I Preferred | Series M Preferred | Series Q Preferred | Series V Preferred | Common Stock | Additional Paid-in | Accumulated | Accumulated Other Comprehensive | Noncontrolling | Total Stockholders’ | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Shares | Amount | Shares | Amount | Shares | Amount | Shares | Amount | Shares | Amount | Shares | Amount | Shares | Amount | Shares | Amount | Capital | Deficit | Deficit | Interest | Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Balance, December 28, 2024 | $ | $ | $ | $ | $ | $ | $ | $ | $ | $ | ( | ) | $ | ( | ) | $ | $ | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Common stock issued for warrants exercised | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Common stock issued for Series V Preferred converted | — | — | — | — | — | — | ( | ) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Common stock issued for consulting agreement | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Foreign currency adjustment | — | — | — | — | — | — | 0 | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Net loss | — | — | — | — | — | — | 0 | — | ( | ) | ( | ) | ( | ) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Balance, March 29, 2025 | ( | ) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Balance, March 29, 2025 | ( | ) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Series A-1 adjustment | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Conversion of Series A-1 Preferred | ( | ) | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ALT5 Sigma Corp common stock issued for RSU’s granted | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ALT5 Sigma Corp common stock issued for note payable obligations | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ALT5 Sigma Corp common stock issued for consulting agreement | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ALT5 Sigma Corp common stock issued for Mswipe acquisition | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ALT5 Sigma Corp common stock warrants for Mswipe acquisition | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Alyea common stock warrants for Mswipe acquisition | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Common stock issued for Series Q convertible stock converted | — | — | — | — | — | ( | ) | ( | ) | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ALT5 Sigma Corp common stock issued for professional services | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Foreign currency adjustment | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Net loss | — | — | — | — | — | — | — | — | ( | ) | ( | ) | ( | ) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Balance, June 28, 2025 | - | $ | $ | $ | $ | $ | $ | $ | $ | $ | $ | ( | ) | $ | $ | $ | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
| 7 |
Note 1: Background
The accompanying consolidated financial statements include the accounts of AI Financial Corporation, a Nevada corporation, and its subsidiaries (collectively, the “Company” or “AIFC”). Effective April 28, 2026, the Company changed its name to “AI Financial Corporation” from “Alt5 Sigma Corporation”. The Company also changed its Nasdaq common stock symbol to “AIFC” from “ALTS.” Previously, effective July 15, 2024, the Company had changed its corporate name to “ALT5 Sigma Corporation” from “JanOne Inc.” and also changed its Nasdaq common stock ticker symbol to “ALTS” from “JAN”. In each instance, the corporate name changes were effected through a parent/subsidiary short-form merger of Company’s wholly-owned Nevada subsidiary formed solely for the purpose of effectuating the name change, whereby that “name change subsidiary” subsidiary merged with and into the Company, with the Company being the surviving entity, albeit with its new name.
The
Company had
Fintech
On May 15, 2024, the Company acquired ALT5 Sigma, Inc. (“ALT5 Subsidiary”). ALT5 Subsidiary is a fintech company that provides next generation blockchain-powered technologies to enable a migration to a new global financial paradigm. ALT5 Subsidiary, through its respective subsidiaries, offers two main platforms to its customers: “ALT5 Pay” and “ALT5 Prime.” ALT5 Pay is a crypto-currency payment gateway that enables registered and approved global merchants to accept and make crypto-currency payments or to integrate the ALT5 Pay payment platform into their application or operations using the plugin with WooCommerce and/or ALT5 Pay’s checkout widgets and APIs. Merchants have the option to convert to fiat currency (US Dollars, Canadian Dollars, Euros, and British Pounds Sterling) automatically or to receive their payment in digital assets (see Note 3).
On May 9, 2025, the Company acquired Fortress II Holdings Ltd. d/b/a Mswipe. Mswipe is a next-generation payment solutions provider offering multi-currency, fiat payment card services, along with crypto-enabled capabilities through its existing integration with the ALT5 Subsidiary platform. Its suite of physical and virtual cards, available on both the Visa® and Mastercard® networks, allows users to seamlessly spend traditional and digital currencies worldwide (see Note 3).
Biotechnology
During
September 2019, the Company, through its biotechnology segment, broadened its business perspectives to become a pharmaceutical company
focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties.
Effective December 28, 2022, the Company acquired Soin Therapeutics LLC, a Delaware limited liability company (“STLLC”),
and its product, a patent-pending, novel formulation of low-dose naltrexone (“JAN123”). The product is being developed for
the treatment of Complex Regional Pain Syndrome (CRPS), an indication that causes severe, chronic pain generally affecting the arms or
legs. At present, there are no truly effective treatments for CRPS. Because of the relatively small number of patients afflicted with
CRPS, the FDA has granted Orphan Drug Designation for any product approved for treatment of CRPS. This designation will provide the Company
with tax credits for its clinical trials, exemption of user fees, and the potential of
| 8 |
Corporate and Other
Our Corporate and Other segment consists of WLFI assets, including any additions, redemptions, or mark-to-market changes in value, which are recorded within the Company’s Corporate and Other segment.
The
WLFI treasury program was initiated on August 12, 2025, with purchases executed in
| 1. | Tranche
1: | |
| 2. | Tranche
2: |
As
of June 27, 2026, all
In connection with the WLFI treasury program, the Company entered into lock-up agreements restricting certain equity issuances. Pursuant to the Purchase Agreements, the Company agreed not to issue, or enter into any agreement to issue, shares of Common Stock or Common Stock equivalents, or file any registration statement or amendment thereto, for a period of 30 days following the closing date of the Offerings, subject to customary exceptions including issuances under the ATM Sales Agreement.
In addition, each of the Company’s directors and executive officers is subject to a lock-up agreement prohibiting the sale, pledge, or other transfer or disposition of 50% of their shares of Common Stock, or securities convertible into or exchangeable for Common Stock, for a period of 90 days following the closing date, with the remaining 50% subject to the same restrictions until the later of 90 days following the closing date or the date Stockholder Approval was obtained. Transfers for bona fide estate or tax planning purposes are permitted, provided the transferee agrees to be bound by the same lock-up terms.
WLFI
is considered a related party to the Company by virtue of the following relationships. Zachary Witkoff, the Chairman of the Company’s
Board of Directors, is a Co-Founder and Chief Executive Officer of WLFI. Zachary Folkman, a member of the Company’s Board of Directors,
is also a Co-Founder of WLFI. In addition, WLFI is the record owner of shares of the Company’s Common Stock and holds
pre-funded warrants to purchase up to
All acquisitions of WLFI tokens were executed through on-chain transactions and direct Token Purchase Agreements with the WLFI Foundation. The Company did not hold any WLFI tokens prior to August 12, 2025.
Our Corporate and Other segment consists of certain corporate general and administrative costs.
The Company reports on a 52- or 53-week fiscal year. The Company’s 2025 fiscal year (“2025”) ended on December 27, 2025, and the current fiscal year (“2026”) will end on December 26, 2026.
| 9 |
Liquidity Considerations
The Company has incurred recurring losses from operations, including a
net loss from continuing operations of approximately $
The Company owns
Based on the current market value of the Company’s WLFI token holdings, the Company believes it possesses sufficient liquidity and financial resources to fund its anticipated operations and satisfy its obligations for at least the next 12 months.
Note 2: Summary of Significant Accounting Policies
Basis of Presentation
The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the U.S. (“U.S. GAAP”) and with the instructions to Form 10-Q and Article 10 of Regulation S-X for interim financial information. Accordingly, these financial statements do not include all of the information and notes required for complete financial statements prepared in conformity with U.S. GAAP. In our opinion, all adjustments, consisting of normal recurring adjustments, considered necessary for a fair presentation have been included. However, the Company’s results of operations for the interim periods presented are not necessarily indicative of the results that may be expected for the full year. For further information, refer to the consolidated financial statements and notes thereto included in our Form 10-K for the fiscal year ended December 27, 2025.
Principles of Consolidation
The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.
Financial Statement Reclassification
Certain prior-period amounts have been reclassified to conform to the current period presentation. These reclassifications relate primarily to the presentation of the Biotechnology segment as discontinued operations.
Use of Estimates
The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumption that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Significant estimates made in connection with the accompanying consolidated financial statements include the fair value in connection with the Series S convertible preferred stock issued in the December 28, 2022 acquisition of STLLC, valuation allowance against deferred tax assets, and estimated useful lives for intangible assets.
Financial Instruments
Financial instruments consist primarily of cash, trade and other receivables, and obligations under accounts payable, accrued expenses and notes payable. The carrying amounts of trade and other receivables, accounts payable, accrued expenses and short-term notes payable approximate fair value because of the short maturity of these instruments. The fair value of the long-term debt is calculated based on interest rates available for debt with terms and maturities similar to the Company’s existing debt arrangements, unless quoted market prices were available (Level 2 inputs). The carrying amounts of long-term debt at June 27, 2026 and December 27, 2025 approximate fair value.
Cryptocurrency Assets
The
Company’s cryptocurrency assets consist of World Liberty Financial (“WLFI”) tokens, a scarce, governance-enabled digital
asset with long-term capital preservation and appreciation potential, inflation-hedging characteristics, and embedded productivity through
protocol participation and revenue-sharing mechanisms. With a fixed maximum supply of
Cryptocurrency assets acquired are initially recorded at cost, which represents the cash, cash equivalents, or other financial assets paid to acquire the asset, including transaction fees. Cryptocurrency assets are subsequently measured in accordance with ASC 350-60, Intangibles—Goodwill and Other—Accounting for and Disclosure of Cryptocurrency Assets, at fair value in the statement of financial position with unrealized gains and losses resulting from changes in fair value recognized in net income. The Company determines and records at each reporting period the fair value of its cryptocurrency assets in accordance with ASC 820, Fair Value Measurement, based on quoted (unadjusted) prices. Changes in the fair value are recognized in net income within “Unrealized gain on crypto assets”, while realized gains and losses from the derecognition of crypto assets are included in “Realized gain on crypto assets, net” in the Company’s condensed consolidated statements of operations. Purchases and redemptions of cryptocurrency assets are reflected as cash flows from investing activities in the consolidated statements of cash flows.
| 10 |
Digital Assets and other Receivables
Digital
assets and other receivables are the Company’s digital assets and its customer prepayments in the form of digital assets. The Company
holds all digital assets in secure non-custodial wallets through the wallet services from Fireblocks. As of June 27, 2026 and December
27, 2025, the outstanding balances of digital assets and other receivables was approximately $
Digital Assets and other Payables
Digital
assets and other payables are liabilities that represent the Company’s obligation to deliver the settlement of transactions in
the form of digital assets and or cash. The Company safeguards these digital assets and/or cash for customers and is obligated to
safeguard them from loss, theft, or other misuse. The Company recognizes digital assets and other payables, on initial recognition
and at each reporting date, at fair value of the digital assets. Any loss, theft, or other misuse would impact the measurement of
digital assets and other payables. As of June 27, 2026, the outstanding balance of digital assets and other payables was
approximately $
Revenue Recognition
Revenue recognition applies to the Company’s Fintech segment only, as the Company’s Biotech segment has not recognized revenue to date. Revenue is recognized under Topic 606 in a manner that reasonably reflects the delivery of its services and products to customers in return for expected consideration and includes the following elements:
| 1. | Executed contracts with the Company’s customers that it believes are legally enforceable; |
| 2. | Identification of performance obligations in the respective contract; |
| 3. | Determination of the transaction price for each performance obligation in the respective contract; |
| 4. | Allocation of the transaction price to each performance obligation; and |
| 5. | Recognition of revenue only when the Company satisfies each performance obligation. |
These five elements, as applied to each of the Company’s revenue category, are summarized below:
| 1. | Product sales – revenue is recognized at the time of sale of equipment to the customer. |
| 2. | Service sales – revenue is recognized based on when the service has been provided to the customer. |
The Company’s service is comprised of a single performance obligation to buy and sell or convert digital assets to currencies. That is, the Company is the counter-party to all transactions between customers and liquidity providers and presents revenue for the fees earned on a net basis.
The Company is acting as principal in all transactions, and control the digital assets being provided before it is transferred to the buyer, and has risk related to the digital assets, and is responsible for the fulfillment of the digital asset transactions. The Company sets the price for the digital assets by aggregating prices from several liquidity providers and displays them on the Company’s platform. As a result, the Company acts as a price discovery service and acts as a principal facilitating the ability for a customer to purchase or sell digital assets.
| 11 |
The Company considers its performance obligation satisfied, and recognizes revenue, at the point in time that the transaction is processed. Contracts with customers are usually open-ended and can be terminated by either party without a termination penalty. Therefore, contracts are defined at the transaction level and do not extend beyond the service already provided.
The Company charges a fee at the transaction level. The transaction price, represented by the trading fee, is calculated based on volume and varies depending on payment type and the value of the transaction. Digital asset purchases or sale transactions executed by a customer on the Company’s platform is based on tiered-pricing that is driven primarily by transaction volume processed for a specific historical period. The Company has concluded that this volume-based pricing approach does not constitute a future material right since the discount is within a range typically offered to a class of customers with similar volume. The transaction fee is collected from the customer at the time the transaction is executed. In certain instances, the transaction fee can be collected in digital assets, with revenue measured based on the amount of digital assets received and the fair value of the digital assets at the time of the transaction. The Company also marks up or down the digital asset prices and earns revenue from the spread between the buying and selling price. The Company also earns a fee from transfers of currencies and or digital assets. The transfer fees are nominal and are set to offset the fees associated with banking and/or blockchain mining fees.
The
Company receives consideration in the form of digital assets as payment for commissions and other fees and utilizes these assets as part
of its working capital. In accordance with ASC 606, the fair value of digital assets received is measured based on quoted prices
in active markets on the date control of the related goods or services transfers to the customer. Subsequent to initial recognition,
the Company measures digital assets at fair value using quoted prices obtained from active, highly liquid exchanges that the Company
has determined to be its principal market. Because these valuations are based on unadjusted quoted prices for identical assets in active
markets, the fair value measurements are classified within Level 1 of the fair value hierarchy. The Company presents these assets
within other current assets on its consolidated balance sheets. As of June 27, 2026, the balance of digital assets included in other
current assets was approximately $
The Company from time to time grants restricted stock units, warrants, and stock options to employees, non-employees, and Company executives and directors. Such awards are valued based on the grant date fair-value of the instruments. The value of each award is amortized on a straight-line basis over the vesting period.
Recently Issued Accounting Pronouncements
In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”). ASU 2023-09 requires enhanced annual disclosures regarding the rate reconciliation and income taxes paid information. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024, and may be adopted on a prospective or retrospective basis. The Company adopted this pronouncement effective with its fiscal year ending December 27, 2025.
Note 3: Mergers and Acquisitions
Block Street
On
April 20, 2026, the Company entered into, a Stock Exchange Agreement (the “SEA”) with the four stockholders of Block Street
Corp., a Nevada corporation (“Block Street”), pursuant to which the Company acquired
| 12 |
The Company evaluated the acquired set under ASC 805 and concluded that it did not meet the definition of a business. Accordingly, the transaction was accounted for as an asset acquisition under ASC 805-50 rather than as a business combination.
The
purchase price for this transaction consisted of
shares of the Company’s common stock issued at closing, valued at approximately $
The
fair value of the purchase price components outlined above was $
Schedule of Business Acquisition
| ALT5 Common stock | $ | |||
| Total purchase price | $ |
The table below outlines the purchase price allocation of the purchase for Block Street to the acquired identifiable intangible assets (in $000’s):
Schedule of Business Acquisition
| Total purchase price | $ | |||
| Total intangible assets acquired | $ |
Mswipe
Effective on May 9, 2025, the Company and our indirect, wholly-owned second-tier Canadian subsidiary entered into an agreement to purchase all of the outstanding capital stock of Fortress II Holdings Ltd. d/b/a Mswipe, an entity that, through its subsidiaries, offers multi-currency, fiat- and crypto-enabled payment card services of Mswipe. The company conducts business under the name Mswipe. Through a suite of physical and virtual cards that are available on both the Visa® and Mastercard® networks, the acquired operations enable users to seamlessly spend traditional and digital currencies across the globe. The platform is built with robust compliance frameworks, advanced security protocols, and real-time exchange capabilities, which allow for fast, secure, and borderless transactions. This is a B2B solution, which, when combined with our other product offerings, bridges the gap between the crypto economy and traditional financial systems—while ensuring regulatory alignment, interoperability with existing payment networks, and a seamless user experience for institutional partners and their end-users.
The
purchase price for this transaction consisted of our (i) issuing
million restricted shares of our common stock to the
| 13 |
The
fair value of the purchase price components outlined above was $
Schedule of Business Acquisition
| ALT5 Common stock | $ | |||
| Common stock warrants | ||||
| Seller notes | ||||
| Alyea Common Stock | ||||
| Total purchase price | $ |
Under
the preliminary purchase price allocation, the Company recognized goodwill of approximately $
Schedule of Assets Liabilities Assumed Goodwill
| Total purchase price | $ | |||
| Accounts payable | ||||
| Total liabilities assumed | ||||
| Total consideration | ||||
| Cash | ||||
| Accounts receivable | ||||
| Property and equipment | ||||
| Intangible assets | ||||
| Customer relationships | ||||
| Trade names | ||||
| Developed technology | ||||
| Subtotal intangible assets | ||||
| Other | ||||
| Total assets acquired | ||||
| Total goodwill |
Proforma Information
The table below presents selected proforma information for the Company for the 13 and 26 weeks ended June 28, 2025, assuming that the acquisition had occurred on December 31, 2023 (the beginning of the Company’s 2024 fiscal year), pursuant to ASC 805-10-50. This proforma information does not purport to represent what the actual results of operations of the Company would have been had the acquisition occurred on that date, nor does it purport to predict the results of operations for future periods (in $000’s).
Schedule of Proforma Information
| As Reported | Adjustments | Proforma | ||||||||||||||
AI Financial Corporation Unaudited 13 weeks ended June 28, 2025 | Mswipe Unaudited 13 weeks ended June 28, 2025 | Adjustments(1) | AI Financial Corporation for the 13 weeks ended June 28, 2025 | |||||||||||||
| Net revenue | $ | $ | $ | |||||||||||||
| Net income | $ | ( | ) | $ | $ | ( | ) | $ | ( | ) | ||||||
| Earnings per basic common share | $ | ( | ) | $ | ( | ) | ||||||||||
| Earnings per basic diluted share | $ | ( | ) | $ | ( | ) | ||||||||||
| As Reported | Adjustments | Proforma | ||||||||||||||
AI Financial Corporation Unaudited 26 weeks ended June 28, 2025 | Mswipe Unaudited 26 weeks ended June 28, 2025 | Adjustments(1) | AI Financial Corporation for the 26 weeks ended June 28, 2025 | |||||||||||||
| Net revenue | $ | $ | $ | |||||||||||||
| Net income | $ | ( | ) | $ | $ | ( | ) | $ | ( | ) | ||||||
| Earnings per basic common share | $ | ( | ) | $ | ( | ) | ||||||||||
| Earnings per basic diluted share | $ | ( | ) | $ | ( | ) | ||||||||||
| (1) |
● Amortization expense of definite-lived intangible assets has been adjusted based on the preliminary fair value at the acquisition date.
Note 4: Discontinued Operations
As of December 27, 2025, the Company has characterized its Biotechnology segment as a discontinued operation on its financial statements, as follows: on May 21, 2025, the Company announced the planned formal separation of its healthcare assets, known as Alyea, and noted that the scope and method of a partial or full disposition, whatever the methodology, would be determined and announced at a later date.
| 14 |
In accordance with the provisions of ASC 360-10 and ASC 205-20, the Company has separately reported the assets and liabilities of the discontinued operations in the consolidated balance sheets. The assets and liabilities have been reflected as discontinued operations in the consolidated balance sheet, as of June 27, 2026 and December 28, 2025, and consists of the following (in $000s):
Schedule Of Discontinued Operations
| June 27, 2026 | December 27, 2025 | |||||||
| Assets from discontinued operations | ||||||||
| Prepaid expenses and other current assets | $ | $ | ||||||
| Total current assets from discontinued operations | ||||||||
| Property and equipment, net 1 | ||||||||
| Intangible assets, net 2 | ||||||||
| Deferred income taxes | ||||||||
| Other assets | ||||||||
| Total other assets from discontinued operations | ||||||||
| Total assets from discontinued operations | $ | $ | ||||||
| Liabilities from discontinued operations | ||||||||
| Accounts payable | $ | $ | ||||||
| Accrued liabilities - other 3 | ||||||||
| Total current liabilities from discontinued operations | ||||||||
| Total noncurrent liabilities from discontinued operations | ||||||||
| Total liabilities from discontinued operations | $ | $ | ||||||
| 1 |
| 2 |
| 3 |
| June 27, 2026 | December 27, 2025 | |||||||
| Projects under construction | $ | $ | ||||||
| Property and equipment | ||||||||
| Property and equipment, gross | ||||||||
| Less accumulated depreciation | ||||||||
| Total property and equipment, net, from discontinued operations | $ | $ | ||||||
| 2 | The Company’s intangible assets consisted of the following (in $000s): |
| June 27, 2026 | December 27, 2025 | |||||||
| Soin intangible | $ | $ | ||||||
| Intangible assets | ||||||||
| Less accumulated amortization | ( | ) | ( | ) | ||||
| Total intangible assets | $ | $ | ||||||
Amortization
expense was $
| 15 |
Soin Intangible Assets
Effective
as of December 28, 2022, the Company acquired Soin Therapeutics LLC, a Delaware limited liability company (“STLLC”), and
its product, a patent-pending, novel formulation of low-dose naltrexone. The assets acquired by the Company consist of 1)
3 The Company’s accrued liabilities consisted of the following (in $000s):
| June 27, 2026 | December 27, 2025 | |||||||
| Due to Dr. Soin | $ | $ | ||||||
| Total accrued expenses | $ | $ | ||||||
In accordance with the provisions of ASC 360-10 and ASC 205-20, the Company has not included in the results of continuing operations the results of operations of the discontinued operations in the consolidated statements of operations and comprehensive income (loss). The results of operations for this entity for the 26 weeks ended June 27, 2026 and June 28, 2025 have been reflected as discontinued operations in the consolidated statements of operations and comprehensive income (loss) and consist of the following (in $000s):
| June 27, 2026 | June 28, 2025 | June 27, 2026 | June 28, 2025 | |||||||||||||
| 13 Weeks Ended | 26 Weeks Ended | |||||||||||||||
| June 27, 2026 | June 28, 2025 | June 27, 2026 | June 28, 2025 | |||||||||||||
| Revenues | $ | $ | $ | $ | ||||||||||||
| Cost of revenues | ||||||||||||||||
| Gross profit | ||||||||||||||||
| Operating expenses from discontinued operations: | ||||||||||||||||
| Selling, general and administrative expenses | ||||||||||||||||
| Total operating expenses from discontinued operations | ||||||||||||||||
| Operating loss from discontinued operations | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
| Other income (expense) from discontinued operations | ||||||||||||||||
| Total other income (loss), net | $ | $ | ||||||||||||||
| Loss before provision for income taxes from discontinued operations | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
| Income tax provision | ||||||||||||||||
| Net loss from discontinued operations | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||
In accordance with the provisions of ASC 360-10 and ASC 205-20, the Company has separately reported the cash flow activity of the discontinued operations in the consolidated statements of cash flows. The cash flow activity from discontinued operations for the 26 weeks ended June 27, 2026 and June 28, 2025 have been reflected as discontinued operations in the consolidated statements of cash flows and consist of the following (in $000s):
| June 27, 2026 | June 28, 2025 | |||||||
| 26 weeks ended | ||||||||
| June 27, 2026 | June 28, 2025 | |||||||
| DISCONTINUED OPERATING ACTIVITIES: | ||||||||
| Net loss from discontinued operations | $ | ( | ) | $ | ( | ) | ||
| Depreciation and amortization | ||||||||
| Noncash expense funded by parent | ||||||||
| Change in deferred taxes | ||||||||
| Changes in assets and liabilities: | ||||||||
| Prepaids and other current assets | ||||||||
| Accounts payable and accrued expenses | ( | ) | ( | ) | ||||
| Net cash used in operating activities from discontinued operations | $ | ( | ) | $ | ||||
| DISCONTINUED INVESTING ACTIVITIES: | ||||||||
| Net cash used in investing activities from discontinued operations | $ | $ | ||||||
| DISCONTINUED FINANCING ACTIVITIES: | ||||||||
| Net cash used in financing activities from discontinued operations | $ | $ | ||||||
| Effect of changes in exchange rate on cash and cash equivalents | ||||||||
| DECREASE IN CASH AND CASH EQUIVALENTS | ||||||||
| CASH AND CASH EQUIVALENTS, beginning of period | ||||||||
| CASH AND CASH EQUIVALENTS, end of period | $ | $ | ||||||
| 16 |
Note 5: Trade and other receivables
The Company’s trade and other receivables as of June 27, 2026 and December 27, 2025, respectively, were as follows (in $000’s):
Schedule of Trade and Other Receivables
| June 27, 2026 | December 27, 2025 | |||||||
| Other receivables | $ | $ | ||||||
| Trade and other receivables, net | $ | $ | ||||||
Note 6: Prepaids and other current assets
Prepaids and other current assets as of June 27, 2026 and December 27, 2025 consist of the following (in $000’s):
Schedule of Other Current Assets
| June 27, 2026 | December 27, 2025 | |||||||
| Prepaid licensing | $ | $ | ||||||
| Prepaid consulting | ||||||||
| Prepaid legal | ||||||||
| Prepaid purchase commitments | ||||||||
| Prepaid rent | ||||||||
| Prepaid insurance | ||||||||
| Prepaid credit card | ||||||||
| Prepaid other | ||||||||
| Total prepaid expenses and other current assets | $ | $ | ||||||
Note 7: Property and Equipment
Property and equipment as of June 27, 2026 and December 27, 2025 consist of the following (in $000’s):
Schedule of Property and Equipment
| June 27, 2026 | December 27, 2025 | |||||||
| Furniture and fixtures | $ | $ | ||||||
| Computer equipment | ||||||||
| Property and equipment | ||||||||
| Property and equipment gross | ||||||||
| Accumulated depreciation | ( | ) | ( | ) | ||||
| Total property and equipment, net | $ | $ | ||||||
Note 8: Leases
In connection with its acquisition of ALT5 Subsidiary (see Note 3), the Company leases commercial office space. These assets and properties are leased under non-cancellable agreements that expire at various future dates. The agreements, which have been classified as operating leases, provide for minimum rent and require the Company to pay all insurance, taxes, and other maintenance costs. As a result, the Company recognizes assets and liabilities for leases with lease terms greater than 12 months. The amounts recognized reflect the present value of remaining lease payments for all leases. The discount rate used is an estimate of the Company’s blended incremental borrowing rate based on information available associated with each subsidiary’s debt outstanding at lease commencement. In considering the lease asset value, the Company considers fixed and variable payment terms, prepayments and options to extend, terminate or purchase. Renewal, termination, or purchase options affect the lease term used for determining lease asset value only if the option is reasonably certain to be exercised.
| 17 |
The following table details the Company’s right of use assets and lease liabilities as of June 27, 2026 and December 27, 2025 (in $000’s):
Schedule of Right of Use Assets and Lease Liabilities
| June 27, 2026 | December 27, 2025 | |||||||
| Right of use asset - operating leases | $ | $ | ||||||
| Lease liabilities: | ||||||||
| Current - operating | ||||||||
| Long term - operating | $ | $ | ||||||
As
of June 27, 2026, the weighted average remaining lease term for operating leases is
Total present value of future lease payments of operating leases as of June 27, 2026 (in $000’s):
Schedule of Lease Payments of Operating Leases
| Twelve months ended | ||||
| 2027 | $ | |||
| 2028 | ||||
| 2029 | ||||
| 2030 | ||||
| Total | ||||
| Less implied interest | ( | ) | ||
| Present value of payments | $ |
Note 9: WLFI Treasury Program
The
WLFI treasury program was initiated on August 12, 2025, with purchases executed in
| ● | Tranche
1: | |
| ● | Tranche
2: |
All acquisitions were executed through on-chain transactions and direct Token Purchase Agreements with the WLFI Foundation. The Company did not hold any WLFI tokens prior to August 12, 2025.
The outstanding units, cost basis, and fair value as of June 27, 2026 were as follows (in $000’s, except for units):
Schedule of Outstanding Units, Cost Basis and Fair Value
| Units | Cost Basis | Fair Value | ||||||||||
| Balance, June 27, 2026: | ||||||||||||
| WLFI | $ | $ | ||||||||||
| Total | $ | $ | ||||||||||
The following table presents a reconciliation of WLFI assets to fair value as of June 27, 2026 (in $000’s):
Schedule of Reconciliation of WLFI Assets to Fair Value
| June 27, 2026 | ||||
| Fair value, December 27, 2025 | $ | |||
| Fair value, beginning balance | $ | |||
| Additions | ||||
| Redemptions | ||||
| Fees paid | ||||
| Subtotal | ||||
| Unrealized loss | ||||
| Fair value, June 27, 2026 | $ | |||
| Fair value, ending balance | $ | |||
| 18 |
During
the 26 weeks ended June 27, 2026, the Company recognized an unrealized loss of approximately $
Note 10: Intangible Assets
Intangible assets as of June 27, 2026 and December 27, 2025 consist of the following (in $000’s):
Schedule of Intangible Assets
| June 27, 2026 | December 27, 2025 | |||||||
| Noncompete agreements | $ | $ | ||||||
| Qoden intangible | ||||||||
| Patents and domains | ||||||||
| Trade names | ||||||||
| Customer relationships | ||||||||
| Block Street intangible | ||||||||
| Developed technology | ||||||||
| Intangible assets | ||||||||
| Total intangible assets gross | ||||||||
| Less accumulated amortization | ( | ) | ( | ) | ||||
| Total intangible assets | $ | $ | ||||||
Intangible
amortization expense was $
Block Street
Effective on April 20, 2026, the Company entered into an agreement to purchase all of the outstanding capital stock of Block Street which operates a platform designed to support token issuances aligned with applicable regulatory frameworks and the tokenization of real-world assets. Block Street’s capabilities have not yet been deployed commercially and Block Street has not generated revenues to date. The Company will amortize the intangible assets over a ten (10)-year period when the assets are placed in service (see Note 3).
Mswipe
Effective on May 9, 2025, the Company and our indirect, wholly-owned second tier Canadian subsidiary entered into an agreement to purchase all of the outstanding capital stock of an entity that, through its subsidiaries, offers multi-currency, fiat- and crypto-enabled payment card services (see Note 3).
Qoden Intangible Assets
On
November 8, 2024, the Company acquired the Qodex Cryptocurrency Exchange Software platform and other related assets from Qoden
Technologies, LLC, a provider of technology solutions for the blockchain industry. The Company will amortize the intangible assets
over a two
ALT5 Subsidiary Intangible Assets
On
May 14, 2024, the Company acquired its ALT5 Subsidiary, which is a fintech company that provides next generation blockchain-powered technologies
to enable a migration to a new global financial paradigm. As part of the acquisition, the Company acquired trade names, customer relationships,
and developed technology, which will be amortized over a period of
Note 11: Goodwill
The following table details the Company’s goodwill as of June 27, 2026 and December 27, 2025 (in $000’s):
Schedule of Goodwill
| Fintech | Biotech | Corporate and Other | Total | |||||||||||||
| December 27, 2025 | ||||||||||||||||
| Balance, Beginning Balance | ||||||||||||||||
| June 27, 2026 | $ | $ | $ | $ | ||||||||||||
| Balance, Ending Balance | $ | $ | $ | $ | ||||||||||||
The
Company accounts for purchased goodwill and intangible assets in accordance with ASC 350, Intangibles—Goodwill and Other. Goodwill
recognized during the 39 weeks ended September 27, 2025 was approximately $
| 19 |
Note 12: Accrued Liabilities
Accrued liabilities as of June 27, 2026 and December 27, 2025 consist of the following (in $000’s):
Schedule of Accrued Liabilities
| June 27, 2026 | December 27, 2025 | |||||||
| Compensation and benefits | $ | $ | ||||||
| Accrued guarantees | ||||||||
| Accrued settlements | ||||||||
| Accrued interest | ( | ) | ||||||
| Accrued professional fees | ||||||||
| Accrued Qoden payments | ||||||||
| Accrued litigation/legal | ||||||||
| Customer deposits | ||||||||
| Other | ||||||||
| Total accrued expenses | $ | $ | ||||||
Note 13: Debentures
Debentures outstanding as of June 27, 2026 and December 27, 2025 consisted for the following (in $000’s):
Schedule of Debenture Outstanding
| June 27, 2026 | December 27, 2025 | |||||||
| Interest
rate of | $ | $ | ||||||
| Total debentures | $ | $ | ||||||
ALT5
Subsidiary issued
During
March 2026,
Note 14: Debt
Long-term debt as of June 27, 2026 and December 27, 2025 consisted of the following (in $000’s):
Schedule of Long-Term Debt
| June 27, 2026 | December 27, 2025 | |||||||
| Fixed deposits | $ | $ | ||||||
| WLFI loan | ||||||||
| Unaffiliated third-party | ||||||||
| Seller notes | ||||||||
| Total notes payable, related parties | ||||||||
| Less current portion | ( | ) | ( | ) | ||||
| Total long-term notes payable, related parties | $ | $ | ||||||
Fixed Deposits
The
Company entered into several Corporate Fixed Deposit Agreements with otherwise unaffiliated third-parties, pursuant to which the Company
became obligated for an aggregate of $
| 20 |
WLFI Loan Agreement
On January 29, 2026, we, through our indirect, wholly-owned subsidiary, ALT5 Digital Holdings, Inc. (“ALT5 Digital” or the “Borrower”), entered into a Master Loan and Security Agreement (the “Loan Agreement”) with WLFI. Zachary Witkoff, Chairman of our Board, is the Chief Executive Officer and Co-Founder of WLFI, and Zachary Folkman, a member of our Board, is the Co-Founder of WLFI.
The
Loan Agreement provides for collateralized loans in the aggregate principal amount of $
The Loan Agreement includes customary representations, warranties, covenants, risk disclosures relating to digital asset collateral, and other terms and conditions customary for transactions of this type, including provisions regarding public disclosure, successor and assignment rights, modification and waiver, notices, and interpretation. The governing law for the Loan Agreement and related documents (other than UCC matters) is the law of the State of Delaware, and disputes are subject to binding arbitration administered by the International Centre for Dispute Resolution seated in Miami, Florida.
On
January 29, 2026, the Borrower drew down the entire $
As of March 28, 2026, the Company pledged , with an additional pledged in the 13 weeks ended June 27, 2026, for a total of WLFI tokens as collateral as of June 27, 2026.
Unaffiliated Third-Party Loans
ICG Note
On
February 7, 2024, the Company amended its outstanding related party promissory obligations (the “ICG Note”) in favor of Isaac
Capital Group LLC (“ICG”) to add a convertibility provision. In accordance with Nasdaq Rules, the per-share conversion price
was set at $, subject to standard adjustments for (i) stock dividends and splits, (ii) subsequent rights offerings, and (iii) pro
rata distributions. The Company’s board of directors provided its approvals of the amendments on February 7, 2024. On March 6,
2024, ICG entered into a Note Purchase Agreement with an otherwise unaffiliated third party, under which the third party acquired the
ICG Note. The terms and conditions of the ICG Note were not modified in connection with its acquisition by the third party. The principal
amount of the ICG Note on the date of acquisition was approximately $
Big/Small Debentures
On
August 20, 2024, the Company entered into
| 21 |
The
Debentures are unsecured and subordinated to any existing or future debt. The Debentures bear interest at a rate of (i)
The
Big Debenture was issued with an original issue discount (an “OID”) initially of $
The
Small Debentures were issued with an OID initially of $
As
of November 1, 2024, the first of the
The
Big Warrant is exercisable, at an exercise price of $
The
Small Warrant is exercisable, at an exercise price of $
As of November 1, 2024, the contingent second tranche of the Warrants vested.
Except
as disclosed with respect to the final tranche of the Big Warrant, each Investor is required to exercise the initial tranche of each
Warrant within
| 22 |
During
the quarter ended June 28, 2025, one of the two non-affiliated Investors exercised the remainder of the Small Warrant for a total of
shares (see Note 17). During the fourth quarter of the year ended December 28, 2024, the non-affiliated Investor exercised the
Big Warrant for a total of shares of the Company’s common stock, and the other two non-affiliated Investors exercised the
Small Warrant for a total of shares. Additionally, during the fourth quarter of the year ended December 28, 2024, these unaffiliated
third-parties agreed to convert a portion their respective investment into Future Equity Agreements of the Company’s subsidiary,
Alyea Therapeutics and, consequently, approximately $
Note 15: Commitments and Contingencies
Litigation
SEC Complaint
On
August 2, 2021, the U.S. Securities and Exchange Commission (“SEC”) filed a civil complaint (the “SEC Complaint”)
in the United States District Court for the District of Nevada naming the Company and one of its executive officers, Virland Johnson,
the Company’s Chief Financial Officer, as defendants (collectively, the “Defendants”). Pursuant to an agreed-upon Order
of the Court, on May 28, 2024, the Company settled its litigation with the SEC. The Settlement Agreement provided, in pertinent part:
“Without admitting or denying the allegations of the complaint (except as provided herein in paragraph 12 and except as to personal
and subject matter jurisdiction, which [the Company] admits), [the Company] hereby consents to the entry of the final Judgment in the
form attached hereto (the “Final Judgment”) and incorporated by reference herein, which, among other things: “(a) permanently
restrains and enjoins [the Company] from violation of Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 thereunder
[15 U.S.C. § 78j(b) and 17 C.F.R. §§ 240.10b-5]; and (c)[sic] orders [the Company] to pay a civil penalty in the amount
of $
The SEC Complaint’s remaining allegations relate to financial, disclosure and reporting violations against the executive officer under Section 10(b) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Rule 10b-5. The SEC Complaint also alleges various claims against the executive officer under Sections 13(a), 13(b)(2)(A), 13(b)(2)(B) and 13(b)(5) of the Exchange Act and Rules 12b-20, 13a-1, 13a-13, 13a-14, 13b2-1, and 13b2-2. The SEC continues to seek a permanent injunction, civil penalties, and an officer-and-director bar against the executive officer. The foregoing is only a general summary of the SEC Complaint, which may be accessed on the SEC’s website at https://www.sec.gov/litigation/litreleases/2021/lr25155.htm.
Sieggreen
In a matter pending in the United States District Court for the District Of Nevada, Case No. 2:21-cv-01517-CDS-EJY, styled as Sieggreen, Individually and On Behalf of All Others Similarly Situated, Plaintiff, v. Live Ventures Incorporated, Jon Isaac, and Virland A. Johnson, Defendants, the Company was added as a defendant on March 6, 2023, and was served on March 23, 2023. Plaintiff has alleged causes of action against the Company for (i) violation of Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder and (ii) violation of Section 10(b) of the Securities Exchange Act of 1934 and Rules 10b-5(a) and 10b-5(c) promulgated thereunder. In June 2023 the Company filed a Motion to Dismiss, which the Court granted with leave for Plaintiffs to file a second amended complaint. Plaintiffs filed their Second Amended Complaint on October 31 2024. On December 16, 2024, the Company filed a Motion to Dismiss, which the Court denied. Thereafter, the Company filed an answer to the Second Amended Complaint. The Company strongly disputes and denies all of the allegations contained therein and will continue to defend itself vigorously against the claims.
| 23 |
Main/270
The
Company is a defendant in an action filed on April 11, 2022, in the U.S. District Court Southern District of Ohio, Eastern Division,
styled, Trustees Main/270, LLC, Plaintiff, vs ApplianceSmart, Inc. and JANONE, Inc., Defendant, Case No.:
2:22-cv-01938-ALM-EPD. The Company was a guarantor of the lease between the Plaintiff and ApplianceSmart, Inc. Plaintiff alleged a
cause of action against the Company in respect of the guaranty and seeks approximately $
Gulf Coast Bank and Trust vs. ALT5 Sigma Corporation, et al.
In
a matter in the United States District Court for the State of Minnesota, Hennepin County, Case No. 27-CV-24-340, styled as Gulf Coast
Bank and Trust Company, Plaintiffs, v ARCA Recycling, Inc., JanOne Inc., and Virland A. Johnson, Defendants; plaintiff sought the
payment of approximately $
Virland Johnson Bankruptcy
On August 14, 2025, the Company received a Summons and Complaint in an Adversary Proceeding (the “Complaint”) filed on August 6, 2025 in connection with the Chapter 7 bankruptcy proceeding titled In re Virland Johnson, No. 2:24-bk-00226-BKM, pending in the United States Bankruptcy Court for the District of Arizona and involving the Company’s former Chief Financial Officer, Virland Johnson. The Complaint alleges that Mr. Johnson had been awarded in October 2023 restricted stock units entitling him to receive shares of the Company’s common stock under the Company’s 2023 Equity Incentive Plan. According to the Complaint, Mr. Johnson did not disclose the existence of the stock award in his January 11, 2024 Chapter 7 bankruptcy petition or accompanying disclosure schedules. The Complaint alleges that the common stock may not have been delivered to Mr. Johnson, may have been assigned by Mr. Johnson to the Company or another unknown assignee, may have been sold by Mr. Johnson, or may even continue to be held by Mr. Johnson. Through the Complaint, the U.S. Trustee seeks to recover the common stock or, if it is no longer available, the equivalent value from the Company on behalf of the bankruptcy estate. On September 30, 2025 the Company filed its Answer to the Complaint and denied the allegations of any wrongdoing by the Company. The Company disputes the allegations concerning the Company and will continue to defend itself vigorously against the claims.
First Capital Consulting, Inc. DBA Trusaic vs. ALT5 Sigma Corporation
In
a matter in the Los Angeles, California Superior Court Case No. 24STCV02261, styled as First Capital Consulting, Inc., Plaintiff
v ALT5 Sigma Corporation, ARCA Recycling, Inc., Customer Connexx LLC; and DOES 3 through 10, inclusive, Defendants; plaintiff is
seeking $
| 24 |
Judgment in Rwanda
ALT
5 Sigma Canada Inc., our indirect-, wholly-owned second-tier Canadian subsidiary, is the subject of certain legal proceedings in the
Rwanda judicial system stemming from issues that allegedly occurred in 2023, prior to the Company’s acquisition of the ALT 5
Subsidiary (and, indirectly, the Canadian subsidiary). At stake in those proceedings is US$
Other Commitments
On
December 30, 2017, the Company disposed of its retail appliance segment and sold ApplianceSmart to Live Ventures Incorporated (“Live Ventures”), a related party.
In connection with that sale, as of January 1, 2022, the Company accrued an aggregate amount of future real property lease payments
of approximately $
The Company is party from time to time to other ordinary course disputes that we do not believe to be material to our financial condition as of June 27, 2026.
Note 16: Registered Direct Offering
Registered Direct Offering
On or about August 12, 2025, the Company entered into securities purchase agreements (the “Registered Offering Purchase Agreements”) with certain institutional investors, pursuant to which the Company agreed to issue to the Purchasers (as defined therein), in a registered direct offering (the “Registered Offering”), an aggregate of shares of the Company’s common stock, par value $ per share (“Common Stock”), at a purchase price of $ per share.
The
Company intends to use up to $
| 25 |
Private Placement Offering
Also,
on August 12, 2025, the Company consummated transactions resulting from a Securities Purchase Agreement (the “Private Placement
Purchase Agreement” and, together with the Registered Offering Purchase Agreements, the “Purchase Agreements”), with
the Lead Investor, pursuant to which the Company received $
Pursuant
to the Private Placement Purchase Agreement, the Lead Investor was issued Common Stock Purchase Warrants (the “Lead Investor Warrants”)
to purchase up to
The issuance and sale of the PIPE Shares, the PIPE Pre-Funded Warrants, the Lead Investor Warrants, and the Lead Investor Shares (collectively, the “PIPE Securities”) were not registered under the Securities Act of 1933, as amended (the “Securities Act”), or any state securities laws. The PIPE Securities were, or will be, as relevant, issued in reliance on the exemption from registration provided by Section 4(a)(2) under the Securities Act and/or Regulation D promulgated thereunder for transactions not involving a public offering. Pursuant to the terms of the Registration Rights Agreement (as defined herein), the Company is required to file a registration statement providing for the resale of the PIPE Securities within 15 days of the closing of the Private Placement. As of the date of this Quarterly Report, the registration statement has not yet been filed.
The
Registered Offering resulted in gross proceeds of $
Pursuant to the Purchase Agreements, the Company has agreed not to issue, enter into any agreement to issue, or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock equivalents, or file any registration statement or any amendment or supplement thereto, for a period of thirty (30) days after the initial registration statement was declared effective, subject to certain customary exceptions, including the use of the Sales Agreement (as defined herein), without the consent of the Purchasers, the Lead Investor, and the Placement Agent.
Placement Agency Agreements
The
Company entered into a Placement Agency Agreement with A.G.P./Alliance Global Partners (the “Placement Agent”), dated August
11, 2025, pursuant to which the Placement Agent acted as the exclusive placement agent for the Company in connection with the Registered
Offering (the “RD Placement Agency Agreement”). Pursuant to the RD Placement Agency Agreement, the Company paid the Placement
Agent a cash fee of
| 26 |
The
Company also entered into a Placement Agency Agreement with the Placement Agent, dated August 11, 2025, pursuant to which the Placement
Agent acted as the exclusive placement agent for the Company in connection with the Private Placement (the “PIPE Placement Agency
Agreement”). Pursuant to the PIPE Placement Agency Agreement, the Company paid the Placement Agent (or its designees) a cash fee
of (i) $
The issuance of the Placement Agent Warrants and the shares of Common Stock underlying the Placement Agent Warrants (the “Placement Agent Warrant Shares”) will not be registered under the Securities Act or any state securities laws. The Placement Agent Warrant Shares will be issued in reliance on the exemption from registration provided by Section 4(a)(2) under the Securities Act and/or Regulation D promulgated thereunder for transactions not involving a public offering.
The Placement Agency Agreement contains customary representations, warranties, and agreements by the Company, customary conditions to closing, indemnification obligations of the Company, other obligations of the parties, and termination provisions.
On
December 30, 2025, the Company entered into an agreement (the “Placement Agent Subsequent Agreement”) with the Placement
Agent that modified certain of the terms of the Placement Agent Agreements. The parties agreed, subject to certain limitations, to extend
the Placement Agent’s irrevocable right of first refusal to act as sole investment banker, sole book-runner, sole sales agent,
and/or sole placement agent, at its sole discretion, for the Company’s future public and private equity and debt offering, including
all equity linked financings, through December 31, 2026, on terms customary to the Placement Agent. The fee tail period, as provided
in the Placement Agent Agreements, was also extended from August 12, 2026 through December 31, 2026. In connection with such extensions,
the Placement Agent (i) paid the Company the sum of one
In connection with the Placement Agent Subsequent Agreement, on December 26, 2025, the Company entered into an agreement with Keefe,
Bruyette & Woods, Inc. (“KBW”), that superseded and terminated the parties’ May 14, 2025 and June 16, 2025, agreements,
which provided that KBW would render certain financial advisory and investment banking services to the Company. Under this agreement,
the Company agreed to pay to KBW the sum of
Registration Rights Agreement
On or about August 11, 2025, the Company and the Lead Investor entered into a Registration Rights Agreement (the “Registration Rights Agreement”) pursuant to which the Company agreed to file a registration statement (the “Resale Registration Statement”), providing for the resale of the PIPE Securities within 15 days of the closing of the Private Placement, to have such registration statement declared effective with 30 days of the filing date (or 60 days, if the SEC conducts a full review) (the date of such effectiveness, the “Effective Date”), and to maintain the effectiveness of such registration statement. As of the date of this Quarterly Report, the registration statement has not yet been filed.
Asset Management Agreement
Further, on or about August 11, 2025 (the “AMA Commencement Date”), the Company entered into an Asset Management Agreement (the “Asset Management Agreement”) with Kraken (the “Asset Manager”), pursuant to which the Asset Manager agreed to provide discretionary investment management services with respect to the Company’s cryptocurrency treasury. The term of the Asset Management Agreement was for thirty (30) days renewable upon the mutual consent of the parties. The Asset Manager received a nominal fee as compensation for its services under the Asset Management Agreement, which was not renewed.
| 27 |
Lock-Up Agreements
Pursuant to the Purchase Agreements, the Company will not issue, enter into any agreement to issue, or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock equivalents, or file any registration statement or any amendment or supplement thereto, for a period of 30 days after the Effective Date, subject to certain customary exceptions, including the use of the Sales Agreement (as defined herein), without the consent of the Purchasers, the Lead Investor and the Placement Agent.
In
addition, each of the Company’s directors and executive officers are subject to a lock-up agreement, which prohibits them from
offering for sale, pledging, announcing the intention to sell, selling, contracting to sell, granting any option, right or warrant to
purchase, or otherwise transferring or disposing of,
Common Stock: Our Articles of Incorporation authorize billion shares of common stock that may be issued from time to time having such rights, powers, preferences and designations as the Board of Directors may determine. During the 13 weeks ended June 28, 2026 and June 28, 2025, shares of common stock were issued in lieu of professional services.
During the quarter ended June 27, 2026, the Company issued shares of its common stock for the acquisition of Block Street.
During
the quarter ended June 28, 2025, the Company issued shares of its common stock to one individual under the Company’s 2023
Equity Incentive Plan. The aggregate value of the shares at issuance was approximately $
During the quarter ended June 28, 2025, the Company issued shares of its common stock to a non-affiliated third-party in exchange for brokerage services rendered.
During
the quarter ended June 28, 2025, the Company issued an aggregate of restricted stock units to Tony Isaac, the Company’s
President. of the restricted stock units were issued from the Company’s 2024 Plan and were issued from the Company’s
2023 Plan. The aggregate value of the shares at issuance was approximately $
During
the quarter ended June 28, 2025, pursuant to the terms and conditions of a related party promissory note, the Company converted approximately
$
During
the quarter ended June 28, 2025, pursuant to the terms and conditions of a related party promissory note, the Company converted approximately
$
On
May 15, 2025, pursuant to the terms and conditions of a promissory note, the Company converted approximately $
On May 9, 2025, the Company acquired Mswipe. As consideration under the acquisition, the Company issued shares of its common stock to the sellers of Mswipe (see Note 3).
On May 2, 2025, the Company entered into a licensing agreement with a non-affiliated third-party, pursuant to which the third-party will provide software licensing and support to the Company. In connection with the agreement, the Company issued to the third-party shares of its common stock.
During the quarter ended March 29, 2025, the Company issued shares of its common stock related to the exercise of warrants under the Small Debenture (see Note 14).
| 28 |
On May 4, 2024, the Company entered into an Asset Purchase Agreement for the purchase of specified assets of an unaffiliated third-party. In connection with this transaction, the Company tendered shares of the Company’s Series V Convertible Preferred Stock. The conversion ratio of the Series V Convertible Preferred Stock is 1:120, meaning every one share of Series V Convertible Preferred Stock, if and when converted into shares of Common Stock shall convert into 120 shares of Common Stock. On March 12, 2025, the unaffiliated third-party exercised all tendered shares of Series V Convertible Preferred Stock into shares of the Company’s common stock.
On January 15, 2025, the Company entered into a six-month consulting agreement with a non-affiliated third-party, pursuant to which the third-party will provide a variety of corporate advisory services related to investment banking matters to the Company. In connection with the agreement, on January 15, 2025, the Company issued to the third-party shares of its common stock.
As of June 27, 2026, and December 27, 2025, there were and shares, respectively, of common stock issued and outstanding, net of shares held in Treasury of as of June 27, 2026.
Equity Offerings: The Company’s 2024 Plan, which was adopted by the Board in November 2024 and approved by the stockholders at the 2024 annual meeting of stockholders, replaces the 2023 Plan, which replaced the 2016 Plan, which replaced the 2011 Plan. Under the 2024 Plan, the maximum aggregate number of shares, which may be subject to or delivered under Awards granted under the Plan is shares. Awards may be in the form of a Stock Award, Option, Stock Appreciation Right, Stock Unit, or Other Stock-based Award granted in accordance with the terms of the respective Plan. During the 13 weeks ended June 28, 2026, there were no grants under the 2024 Plan.
The Company’s 2023 Plan, which was adopted by the Board in August 2023 and approved by the stockholders at the 2023 Annual Meeting of Stockholders, replaces the 2016 Plan, which replaced the 2011 Plan. Under the 2023 Plan, the maximum aggregate number of shares, which may be subject to or delivered under Awards granted under the Plan is two million () shares. Awards may be in the form of a Stock Award, Option, Stock Appreciation Right, Stock Unit, or Other Stock-based Award granted in accordance with the terms of the respective Plan. During the 13 weeks ended June 28, 2026 and June 28, 2025, the Company recognized $ and $ in share-based compensation expense related to the RSU’s that were awarded and immediately vested.
The Company’s 2016 Plan authorizes the granting of awards in any of the following forms: (i) incentive stock options, (ii) nonqualified stock options, (iii) restricted stock awards, and (iv) restricted stock units, and expires on the earlier of October 28, 2026, or the date that all shares reserved under the 2016 Plan are issued or no longer available. On November 4, 2020, the Company amended the 2016 Plan to increase the issuance of common shares from to . The vesting period is determined by the Board of Directors at the time of the stock option grant. As of June 28, 2026 and December 27, 2025, options were outstanding under the 2016 Plan.
The Company’s 2011 Plan authorizes the granting of awards in any of the following forms: (i) stock options, (ii) stock appreciation rights, and (iii) other share-based awards, including but not limited to, restricted stock, restricted stock units or performance shares, and expired on the earlier of May 12, 2021, or the date that all shares reserved under the 2011 Plan are issued or no longer available. As of June 28, 2026 and December 27, 2025, were outstanding under the 2011 Plan. No additional awards will be granted under the 2011 Plan.
The fair value of each stock option grant is estimated on the date of grant using the Black-Scholes option pricing model. There were no stock options granted during the 13 weeks ended June 27, 2026.
| 29 |
Schedule of Additional Information Relating to All Outstanding Stock Options
Options Outstanding | Weighted Average Exercise Price | Aggregate Intrinsic Value | Weighted Average Remaining Contractual Life | |||||||||||||
| Outstanding at December 27, 2025 | $ | $ | ||||||||||||||
| Outstanding at March 28, 2026 | $ | $ | ||||||||||||||
| Outstanding at June 27, 2026 | $ | $ | ||||||||||||||
| Exercisable at June 27, 2026 | $ | $ | ||||||||||||||
The Company recognized $ and $ in share-based compensation expense related to restricted stock units for the 13 weeks ended June 27, 2026 and June 28, 2025, respectively, and $ and $ for the 26 weeks ended June 27, 2026 and June 28, 2025, respectively.
As of June 27, 2026, the Company had unrecognized share-based compensation expense associated with equity awards.
Series I Convertible Preferred Stock
Shares
of Series I Preferred Stock are convertible into the Company’s common shares at a ratio of
Series Q Convertible Preferred Stock
Shares
of Series Q Preferred Stock are convertible into the Company’s common shares at a ratio of
Series S Preferred Stock
On
December 28, 2022 the Company acquired Soin Therapeutics LLC, by way of a triangular merger. In connection with this transaction,
with a potential value of up to $
Series V Convertible Preferred Stock
Shares
of Series V Preferred Stock are convertible into the Company’s common shares at a ratio of
Note 18: Mezzanine Equity
During
the year ended December 28, 2024, the Company reclassified approximately $
| 30 |
Net income (loss) per share is calculated using the weighted average number of shares of common stock outstanding during the applicable period. Basic weighted average common shares outstanding do not include shares of restricted stock that have not yet vested, although such shares are included as outstanding shares in the Company’s Consolidated Balance Sheet. Diluted net income (loss) per share is computed using the weighted average number of common shares outstanding and if dilutive, potential common shares outstanding during the period. Potential common shares consist of the additional common shares issuable in respect of restricted share awards, stock options, warrants, and convertible preferred stock.
Schedule of Computation of Basic and Diluted Net Loss Per Share
| June 27, 2026 | June 28, 2025 | June 27, 2026 | June 28, 2025 | |||||||||||||
| For the Thirteen Weeks Ended | For the Twenty-Six Weeks Ended | |||||||||||||||
| June 27, 2026 | June 28, 2025 | June 27, 2026 | June 28, 2025 | |||||||||||||
| Continuing Operations | ||||||||||||||||
| Basic and diluted | ||||||||||||||||
| Net loss from continuing operations | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||
| Weighted average common shares outstanding | ||||||||||||||||
| Basic and diluted loss per share from continuing operations | $ | ) | $ | ) | $ | ) | $ | ) | ||||||||
| Discontinued Operations | ||||||||||||||||
Basic and diluted | ||||||||||||||||
| Net loss from discontinuing operations | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||
| Weighted average common shares outstanding | ||||||||||||||||
Basic and diluted loss per share from discontinuing operations | $ | ) | $ | ) | $ | ) | $ | ) | ||||||||
| Total | ||||||||||||||||
| Basic and diluted | ||||||||||||||||
| Net (loss) income | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||
| Weighted average common shares outstanding | ||||||||||||||||
| Basic and diluted loss per share | $ | ) | $ | ) | $ | ) | $ | ) | ||||||||
Potentially dilutive securities totaling approximately million and million were excluded from the calculation of diluted earnings per share for the 13 weeks ended June 27, 2026 and June 28, 2025, respectively, and million and million were excluded from the calculation of diluted earnings per share for the 26 weeks ended June 27, 2026 and June 28, 2025, respectively, because the effects were anti-dilutive.
Note 20: Income Taxes
The
Company recorded an income tax benefit from continuing operations of approximately $
Note 21: Segment Information
The
Company operates within targeted markets through
| 31 |
The following tables present the Company’s segment information for the 13 and 26 weeks ended June 27, 2026 and June 28, 2025 (in $000’s):
Schedule of Segment Information
| June 27, 2026 | June 28, 2025 | June 27, 2026 | June 28, 2025 | |||||||||||||
| Thirteen Weeks Ended | Twenty-Six Weeks Ended | |||||||||||||||
| June 27, 2026 | June 28, 2025 | June 27, 2026 | June 28, 2025 | |||||||||||||
| Revenues | ||||||||||||||||
| Fintech | $ | $ | $ | $ | ||||||||||||
| Corporate and other | ||||||||||||||||
| Discontinued operations | ||||||||||||||||
| Total Revenues | $ | $ | $ | $ | ||||||||||||
| Gross profit | ||||||||||||||||
| Fintech | $ | $ | $ | $ | ||||||||||||
| Corporate and other | ||||||||||||||||
| Discontinued operations | ||||||||||||||||
| Total Gross profit | $ | $ | $ | $ | ||||||||||||
| Operating income (loss) | ||||||||||||||||
| Fintech | $ | $ | ( | ) | $ | $ | ( | ) | ||||||||
| Corporate and other | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
| Discontinued operations | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
| Total Operating loss | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||
| Depreciation and amortization | ||||||||||||||||
| Fintech | $ | $ | $ | $ | ||||||||||||
| Corporate and other | ||||||||||||||||
| Discontinued operations | ||||||||||||||||
| Total Depreciation and amortization | $ | $ | $ | $ | ||||||||||||
| Interest expense, net | ||||||||||||||||
| Fintech | $ | $ | $ | $ | ||||||||||||
| Corporate and other | ||||||||||||||||
| Discontinued operations | ||||||||||||||||
| Total Interest expense, net | $ | $ | $ | $ | ||||||||||||
| Net loss before income taxes | ||||||||||||||||
| Fintech | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||
| Corporate and other | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
| Discontinued operations | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
| Total net loss before income taxes | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||
Note 22: Related Parties
Shared Services
Tony
Isaac, the Company’s President, is the father of Jon Isaac, President and Chief Executive Officer of Live Ventures and managing
member of Isaac Capital Group LLC (“ICG”). Tony Isaac is a member of the Board of Directors of Live Ventures. The Company
also shares certain executive, accounting and legal services with Live Ventures. The total services shared were approximately $
| 32 |
Note 23: Subsequent Events
The Company has evaluated subsequent events through the filing of this Form 10-Q, and determined that there have been no events that have occurred that would require adjustments to disclosures in its condensed consolidated financial statements other than as discussed below:
Sale of ALT5 Sigma Canada, Inc.
On
July 29, 2026, the Company and its first tier, wholly -(a Delaware corporation referenced in Note 1 as the “ALT5 Subsidiary”),
owned subsidiary, Alt 5 Sigma, Inc., entered into an Acquisition Agreement with Prime Delta Corp., a Delaware corporation (“Prime
Delta”), pursuant to which the Alt 5 Subsidiary sold to Prime Delta all of the issued and outstanding shares of Alt 5 Sigma Canada,
Inc. (“Alt 5 Canada”; referenced in these Notes as our indirect, wholly-owned second tier Canadian subsidiary), through which
the Company conducted its payments business. In exchange, the Company received the following consideration: (i) a four (
The Prime Delta Note is secured by substantially all of the assets of Prime Delta and is guaranteed by certain affiliates of Prime Delta. In connection with the transaction, the Company assigned to Prime Delta the “Alt 5” and “Alt 5 Sigma” trademarks and related rights, agreed to cease use of those names, and agreed to change the names of its subsidiaries whose legal names include “Alt 5” within 90 days following the closing.
Additionally, through counsel for Prime Delta, the Company may offer the holders of its Series B Preferred Stock the opportunity to redeem their shares of Series B Preferred Stock, on a consensual basis, in exchange for their pro rata share of up to shares of Prime Delta Stock, on a one share of Series B Preferred Stock -for-one share of Prime Delta Stock basis. No such redemption offer has commenced and no documentation has been prepared or filed, as applicable.
Amendments to Promissory Notes and Warrants
Effective
July 7, 2026, the Company entered into Extension and First Amendment Agreements with the holders of ten promissory notes with an
aggregate principal amount of CAD$
Concrete Agreement
On July 30, 2026, Alt5 Digital Holdings, Inc., a Wyoming corporation and indirect, wholly-owned subsidiary of the
Company (“Alt5 Digital”), and Concrete Network Services Ltd, a BVI business company (“Concrete”), entered into
a two-year Master Services Agreement (the “Agreement”), pursuant to which the parties determined that Concrete would provide
certain services to Alt 5 Digital through two separate Statements of Work (the “SOWS”). The services are generally described
as vault infrastructure and related services on an exclusive basis in respect of $
| 33 |
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) is intended to provide a reader of our financial statements with a narrative from the perspective of our management on our financial condition, results of operations, liquidity and certain other factors that may affect our future results. Dollars stated in thousands, except per–share amounts.
Forward-Looking and Cautionary Statements
This Quarterly Report on Form 10-Q contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of Exchange Act, which involve risks and uncertainties. You can identify forward-looking statements because they contain words such as ‘‘believes,’’ ‘‘expects,’’ ‘‘may,’’ ‘‘will,’’ ‘‘should,’’ ‘‘seeks,’’ ‘‘approximately,’’ ‘‘intends,’’ ‘‘plans,’’ ‘‘estimates’’ or ‘‘anticipates’’ or similar expressions that concern our strategy, plans or intentions. Any statements we make relating to our future operations, performance and results, and anticipated liquidity are forward-looking statements. All forward-looking statements are subject to risks and uncertainties that may change at any time, and, therefore, our actual results may differ materially from those we expected. We derive most of our forward-looking statements from our operating budgets and forecasts, which are based upon many detailed assumptions. While we believe that our assumptions are reasonable, we caution that it is very difficult to predict the impact of known factors, and, of course, it is impossible for us to anticipate all factors that could affect our actual results. Important factors that could cause actual results to differ materially from our expectations, including, without limitation, in conjunction with the forward-looking statements included in this Quarterly Report on Form 10-Q, are disclosed in “Item 1-Business, Item 1A – Risk Factors” of our Annual Report on Form 10-K for the fiscal year ended December 27, 2025, and Part II, Item 1A of this Report.
We undertake no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law. Our MD&A should be read in conjunction with our Form 10-K (including the information presented therein under the caption Risk Factors), together with our Quarterly Reports on Forms 10-Q and other publicly available information. All amounts herein are unaudited.
Our Company
Through our Fintech segment, we provide next generation blockchain-powered technologies to enable a migration to a new global financial paradigm, and, through our Biotechnology segment, we are focused on finding treatments for conditions that cause chronic pain and bringing to market drugs with non-addictive and non-sedative pain-relieving properties.
During the periods disclosed in this Quarterly Report, we operated three reportable segments:
Fintech
Our Fintech segment provides next generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment, and safe-keeping of digital assets
Biotechnology
Our Biotechnology segment is focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties. We have previously announced our intention to capitalize a subsidiary with certain of our biotechnology assets, acquire an additional biotechnology asset, and then engage in a financing of that subsidiary. The short-term intended result of that series of transactions would be for to decouple it from us so that it would operate on a stand-alone basis. The Biotech segment is being presented as discontinued operations for the 13 and 26 weeks ended June 27, 2026 and June 28, 2025.
| 34 |
Corporate and Other
In August 2025, we closed a $1.5 billion registered direct offering and concurrent private placement to launch our WLFI Treasury Strategy. This “capital with a purpose” financing positioned the Company as one of the most significant institutional holders of WLFI, securing a meaningful stake in the native governance token of the World Liberty Financial ecosystem.
Our policy remains a committed long-term “HODL” approach, with future acquisitions funded through operating cash flows, structured debt, and selective capital raises. Sales are restricted to liquidity requirements or material portfolio rebalancing events.
Our Corporate and Other segment consists of WLFI assets, including any additions, redemptions, or mark-to-market changes in value, are recorded within the Company’s Corporate and Other segment.
Our Corporate and Other segment consists of certain corporate general and administrative costs.
For the Thirteen Weeks Ended June 27, 2026 and June 28, 2025
Results of Operations
The following table sets forth certain statement of operations items and as a percentage of revenue, for the periods indicated (in $000’s):
| 13 Weeks Ended | 13 Weeks Ended | |||||||
| June 27, 2026 | June 28, 2025 | |||||||
| Statement of Operations Data: | ||||||||
| Revenue | $ | 2,414 | $ | 6,378 | ||||
| Gross profit | 2,355 | 2,775 | ||||||
| Selling, general and administrative expenses | 3,063 | 4,870 | ||||||
| Interest (expense), net | (570 | ) | (550 | ) | ||||
| Unrealized loss on cryptocurrency assets | (285,149 | ) | — | |||||
| Unrealized gain on exchange transactions | 41 | 211 | ||||||
| Realized gain (loss) on exchange transactions | 520 | (3,485 | ) | |||||
| Other (expense), net | 376 | (15 | ) | |||||
| Net loss from continuing operations before provision of income taxes | (285,490 | ) | (5,934 | ) | ||||
| Income tax provision (benefit) from continuing operations | 57,143 | (432 | ) | |||||
| Net loss from continuing operations | (228,347 | ) | (5,502 | ) | ||||
| Net loss from discontinued operations before provision of income taxes | $ | (1,210 | ) | $ | (657 | ) | ||
| Income tax expense from discontinued operations | — | 2,956 | ||||||
| Net loss from discontinued operations | $ | (1,210 | ) | $ | (3,613 | ) | ||
| Net loss | $ | (229,557 | ) | $ | (9,115 | ) | ||
The following tables set forth revenues for key product and service categories, percentages of total revenue and gross profits earned by key product and service categories and gross profit percent as compared to revenues for each key product category indicated (in $000’s):
| 13 Weeks Ended | 13 Weeks Ended | |||||||||||||||
| June 27, 2026 | June 28, 2025 | |||||||||||||||
| Net Revenue | Percent of Total | Net Revenue | Percent of Total | |||||||||||||
| Revenue | ||||||||||||||||
| Fintech | $ | 2,414 | 100.0 | % | $ | 6,378 | 100.0 | % | ||||||||
| Corporate & Other | — | — | % | — | — | % | ||||||||||
| Discontinued operations | — | — | % | — | — | % | ||||||||||
| Total revenue | $ | 2,414 | 100.0 | % | $ | 6,378 | 100.0 | % | ||||||||
| 35 |
| 13 Weeks Ended | 13 Weeks Ended | |||||||||||||||
| June 27, 2026 | June 28, 2025 | |||||||||||||||
| Gross Profit | Gross Profit Percentage | Gross Profit | Gross Profit Percentage | |||||||||||||
| Gross Profit | ||||||||||||||||
| Fintech | $ | 2,355 | 97.6 | % | $ | 2,775 | 43.5 | % | ||||||||
| Corporate & Other | — | — | % | — | — | % | ||||||||||
| Discontinued operations | — | — | % | — | — | % | ||||||||||
| Total gross profit | $ | 2,355 | 97.6 | % | $ | 2,775 | 43.5 | % | ||||||||
Revenue
Revenue decreased by approximately $4.0 million for the 13 weeks ended June 27, 2026, as compared to the 13 weeks ended June 28, 2025. The decrease is due to the loss of a large customer.
Gross Profit
Gross profit decreased by approximately $0.4 million for the 13 weeks ended June 27, 2026, as compared to the 13 weeks ended June 28, 2025. The decrease is primarily due to the loss of a large customer.
Selling, General and Administrative Expense
Selling, general and administrative expenses decreased by approximately $1.8 million for the 13 weeks ended June 27, 2026, as compared to the 13 weeks ended June 28, 2025, primarily due to lower labor costs and the higher costs due to the acquisition of Mswipe in 2025.
Unrealized Loss on Cryptocurrency Assets
Unrealized loss on cryptocurrency assets for the 13 weeks ended June 27, 2026 was approximately $285.1 million. An unrealized gain or loss on cryptocurrency assets was recorded to mark the fair value of the WLFI tokens.
Segment Performance
We report our business in the following segments: Fintech, Biotechnology and Corporate and Other. During fiscal 2025, the Company announced its intent to formally separate its Biotechnology segment, also known as Alyea. Consequently, the Biotech segment is being presented as discontinued operations for the 13 weeks ended June 27, 2026 and June 28, 2025.
| 36 |
Operating loss by operating segment, is defined as loss before net interest expense, other income and expense, provision for income taxes ($000’s).
| 13 Weeks Ended June 27, 2026 | 13 Weeks Ended June 28, 2025 | |||||||||||||||||||||||||||||||
| Fintech | Corporate and Other | Biotech (Discontinued Operations) | Total | Fintech | Corporate and Other | Biotech (Discontinued Operations) | Total | |||||||||||||||||||||||||
| Revenue | $ | 2,414 | $ | — | $ | — | $ | 2,414 | $ | 6,378 | $ | — | $ | — | $ | 6,378 | ||||||||||||||||
| Cost of revenue | 59 | — | — | 59 | 3,603 | — | — | 3,603 | ||||||||||||||||||||||||
| Gross profit | 2,355 | — | — | 2,355 | 2,775 | — | — | 2,775 | ||||||||||||||||||||||||
| Selling, general and administrative expense | (263 | ) | 3,326 | 1,210 | 4,273 | 3,854 | 1,016 | 657 | 5,527 | |||||||||||||||||||||||
| Operating income (loss) | $ | 2,618 | $ | (3,326 | ) | $ | (1,210 | ) | $ | (1,918 | ) | $ | (1,079 | ) | $ | (1,016 | ) | $ | (657 | ) | $ | (2,752 | ) | |||||||||
Fintech Segment
Our Fintech segment consists of ALT5 Subsidiary, which was acquired during May 2024, as well as Mswipe, which was acquired during May 2025. Revenue for the 13 weeks ended June 28, 2026 was approximately $2.4 million, and gross margin percentage was 97.6%. Operating income for the fiscal year ended 13 weeks ended June 27, 2026 was approximately $2.6 million.
Corporate and Other Segment
Our Corporate and Other segment generated no revenue for the for the 13 weeks ended June 27, 2026 and the 13 weeks ended June 28, 2025. Selling, general and administrative expenses increased primarily due to increased labor costs.
Biotechnology Segment
During fiscal 2025, the Company announced its intent to formally separate its Biotechnology segment, also known as Alyea. Consequently, the Biotech segment is being presented as discontinued operations for the 13 weeks ended June 27, 2026 and June 28, 2025. Our Biotech segment generated no revenue for the 13 weeks ended June 27, 2026 and the 13 weeks ended June 28, 2025. Selling, general and administrative expenses increased $0.5 million due to increased research and development expenses.
| 37 |
For the Twenty-six Weeks Ended June 27, 2026 and June 28, 2025
Results of Operations
The following table sets forth certain statement of operations items and as a percentage of revenue, for the periods indicated (in $000’s):
| 26 Weeks Ended | 26 Weeks Ended | |||||||
| June 27, 2026 | June 28, 2025 | |||||||
| Statement of Operations Data: | ||||||||
| Revenue | $ | 7,126 | $ | 11,892 | ||||
| Gross profit | 5,929 | 5,366 | ||||||
| Selling, general and administrative expenses | 9,380 | 9,091 | ||||||
| Interest expense, net | (1,076 | ) | (1,270 | ) | ||||
| Unrealized loss on cryptocurrency assets | (633,450 | ) | — | |||||
| Unrealized gain on exchange transactions | — | 298 | ||||||
| Realized gain on exchange transactions | (5,562 | ) | (3,177 | ) | ||||
| Other income (expense), net | 1,654 | (96 | ) | |||||
| Loss from continuing operations before provision of income taxes | (641,885 | ) | (7,970 | ) | ||||
| Income tax provision (expense) from continuing operations | 142,223 | (147 | ) | |||||
| Net loss from continuing operations | $ | (499,662 | ) | $ | (7,823 | ) | ||
| Loss from discontinued operations before provision of income taxes | (1,387 | ) | (1,197 | ) | ||||
| Income tax expense from discontinued operations | — | 2,956 | ||||||
| Net loss from discontinued operations | $ | (1,387 | ) | $ | (4,153 | ) | ||
| Net loss | $ | (501,049 | ) | $ | (11,976 | ) | ||
The following tables set forth revenues for key product and service categories, percentages of total revenue and gross profits earned by key product and service categories and gross profit percent as compared to revenues for each key product category indicated (in $000’s):
| 26 Weeks Ended | 26 Weeks Ended | |||||||||||||||
| June 27, 2026 | June 28, 2025 | |||||||||||||||
| Net Revenue | Percent of Total | Net Revenue | Percent of Total | |||||||||||||
| Revenue | ||||||||||||||||
| Fintech | $ | 7,126 | 100.0 | % | $ | 11,892 | 100.0 | % | ||||||||
| Corporate & Other | — | — | % | — | — | % | ||||||||||
| Discontinued operations | — | — | % | — | — | % | ||||||||||
| Total revenue | $ | 7,126 | 100.0 | % | $ | 11,892 | 100.0 | % | ||||||||
| 26 Weeks Ended | 26 Weeks Ended | |||||||||||||||
| June 27, 2026 | June 28, 2025 | |||||||||||||||
| Gross Profit | Gross Profit Percentage | Gross Profit | Gross Profit Percentage | |||||||||||||
| Gross Profit | ||||||||||||||||
| Fintech | $ | 5,929 | 83.2 | % | $ | 5,366 | 45.1 | % | ||||||||
| Corporate & Other | — | — | % | — | — | % | ||||||||||
| Discontinued operations | — | — | % | — | — | % | ||||||||||
| Total gross profit | $ | 5,929 | 83.2 | % | $ | 5,366 | 45.1 | % | ||||||||
Revenue
Revenue decreased by approximately $4.8 million for the 26 weeks ended June 27, 2026, as compared to the 26 weeks ended June 28, 2025. The decrease is due to the loss of a major customer.
| 38 |
Gross Profit
Gross profit increased by approximately $0.6 million for the 26 weeks ended June 27, 2026, as compared to the 26 weeks ended June 28, 2025. The increase is due to the loss of a large low margin customer.
Selling, General and Administrative Expense
Selling, general and administrative expenses increased by approximately $0.3 million for the 26 weeks ended June 27, 2026, as compared to the 26 weeks ended June 28, 2025, the decrease is due an increase in professional fees in 2026 and due to higher costs due to the acquisition of Mswipe in 2025.
Interest Expense, net
Interest expense, net decreased by approximately $0.2 million for the 26 weeks ended June 27, 2026, as compared to the 26 weeks ended June 28, 2025 primarily due to pay down of debt.
Unrealized Loss on Cryptocurrency Assets
Unrealized loss on cryptocurrency assets for the 26 weeks ended June 27, 2026 was approximately $633.5 million. An unrealized gain or loss on cryptocurrency assets was recorded to mark the fair value of the WLFI tokens.
Segment Performance
We report our business in the following segments: Fintech, Biotechnology and Corporate and Other. During fiscal 2025, the Company announced its intent to formally separate its Biotechnology segment, also known as Alyea. As a result, the Biotech segment is being presented as discontinued operations for the 26 weeks ended June 27, 2026 and June 28, 2025.
Operating loss by operating segment, is defined as loss before net interest expense, other income and expense, provision for income taxes ($000’s).
| 26 Weeks Ended June 27, 2026 | 26 Weeks Ended June 28, 2025 | |||||||||||||||||||||||||||||||
| Fintech | Corporate and Other | Biotech (Discontinued Operations) | Total | Fintech | Corporate and Other | Biotech (Discontinued Operations | Total | |||||||||||||||||||||||||
| Revenue | $ | 7,126 | $ | — | $ | — | $ | 7,126 | $ | 11,892 | $ | — | $ | — | $ | 11,892 | ||||||||||||||||
| Cost of revenue | 1,197 | — | — | 1,197 | 6,526 | — | — | 6,526 | ||||||||||||||||||||||||
| Gross profit | 5,929 | — | — | 5,929 | 5,366 | — | — | 5,366 | ||||||||||||||||||||||||
| Selling, general and administrative expense | 4,949 | 4,431 | 1,387 | 10,767 | 5,611 | 2,283 | 1,197 | 9,091 | ||||||||||||||||||||||||
| Operating (loss) income | $ | 980 | $ | (4,431 | ) | $ | (1,387 | ) | $ | (4,838 | ) | $ | (245 | ) | $ | (2,283 | ) | $ | (1,197 | ) | $ | (3,725 | ) | |||||||||
Fintech Segment
Our Fintech segment consists of ALT5 Subsidiary, which was acquired during May 2024, as well as Mswipe, which was acquired during May 2025. Revenue for the 26 weeks ended June 27, 2026 was approximately $7.1 million, and gross margin percentage was 83.2%. Operating income for the fiscal year ended 26 weeks ended June 28, 2025 was approximately $1.0 million.
Corporate and Other Segment
Our Corporate and Other segment generated no revenue for the for the 26 weeks ended June 27, 2026 and the 26 weeks ended June 28, 2025. Selling, general and administrative expenses increased primarily due to increased costs for labor, accounting and public company expenses.
| 39 |
Biotechnology Segment
During fiscal 2025, the Company announced its intent to formally separate its Biotechnology segment, also known as Alyea. As a result, the Biotech segment is being presented as discontinued operations for the 26 weeks ended June 27, 2026 and June 28, 2025. Our Biotech segment generated no revenue for the for the 26 weeks ended June 27, 2026 and the 26 weeks ended June 28, 2025. Selling, general and administrative expenses were primarily due to research and development expenses.
Liquidity and Capital Resources
Overview
As of June 27, 2026, our cash on hand net of reserve, was $3.1 million. Approximately $3.5 million of cash has been fully reserved in connection with the legal matter, further described in Note 15 to the consolidated financial statements. We intend to raise funds either through capital raises or structured arrangements, which would include effectuating our previously announced intention to capitalize a subsidiary with certain of our biotechnology assets, acquire an additional biotechnology asset, and then engage in a financing of that subsidiary. The short-term intended result of that series of transactions would be for us to own a controlling interest in that subsidiary, but to decouple it from us so that it would operate on a stand-alone basis, although its financial statements would continue to be consolidated with ours for as long as we have a controlling interest.
Cash Flows
During the 26 weeks ended June 27, 2026, cash used in continuing operations was approximately $18.5 million, compared to cash used in continuing operations of approximately $6.7 million during the 26 weeks ended June 28, 2025. The decrease in cash was primarily due an unrealized loss on crypto currency assets offset by a change in deferred tax liability.
Cash used in investing activities for continued operations was $0.5 million for the 26 weeks ended June 27, 2026, compared to cash provided by investing activities of $0.1 million for the 26 weeks ended June 28, 2025. Cash provided by investing activities for the 26 weeks ended June 28, 2025 was related to the purchase of treasury shares offset by the acquisition of Mswipe, in 2025. There was no cash used in investing activities for discontinued operations during the 26 weeks ended June 27, 2026 or June 28, 2025.
Cash provided by financing activities was $10.7 million for the 26 weeks ended June 27, 2026, and relates to proceeds from notes payable, partially offset by purchases of short-term certificates of deposits and cash paid for notes payable. Cash provided by financing activities was approximately $3.7 million for the 26 weeks ended June 28, 2025, and relates to proceeds received from the issuance of notes payable, as well as warrants converted to our common stock, partially offset by cash paid for notes payable and related party notes payable. There was no cash provided by financing activities for discontinued operations during the 26 weeks ended June 27, 2026 or June 28, 2025.
Future Sources of Cash; Phase 2b Trials, New Acquisitions, Products, and Services
We may require additional debt financing and/or capital to finance new acquisitions, conduct our Phase IIb clinical trials for our Biotechnology segment, or consummate other strategic investments in our business. No assurance can be given any financing obtained may not further dilute or otherwise impair the ownership interest of our existing stockholders.
Item 3. Quantitative and Qualitative Disclosures about Market Risk
Market Risk and Impact of Inflation
Interest Rate Risk. We do not believe there is any significant risk related to interest rate fluctuations on our short and long-term fixed rate debt.
We do not hold any derivative financial instruments, nor do we hold any securities for trading or speculative purposes.
| 40 |
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Evaluation of Disclosure control and Procedures. We carried out an evaluation, under the supervision, and with the participation of our management, including our principal executive officer and principal financial officer, of the effectiveness of our disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)). Based upon that evaluation, our principal executive officer and principal financial officer concluded that, as of June 27, 2026, the period covered in this report, our disclosure controls and procedures were not effective to ensure that information required to be disclosed in reports filed under the Exchange is recorded, processed, summarized and reported within the required time periods and is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure due to material weaknesses in internal control over financial reporting further described below.
Despite the identified material weaknesses, management concluded that the consolidated financial statements included in this Quarterly Report on Form 10-Q present fairly, in all material respects, the financial position, results of operations and cash flows for the periods disclosed in conformity with GAAP. LJ Soldinger Associates, LLC, the Company’s independent registered public accounting firm, issued an unqualified opinion on our consolidated financial statements as of and for the year ended December 27, 2025. They were not engaged to perform, and did not perform, an audit of internal control over financial reporting. This material weakness has no impact on our consolidated financial statements in prior years.
Management’s Report on Internal Control Over Financial Reporting. Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)). Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
The Company’s management, including our CEO and CFO, do not expect that the Company’s disclosure controls and procedures or the Company’s internal control over financial reporting will prevent or detect all errors and all fraud. A control system, regardless of how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system will be met. These inherent limitations include the following: judgments in decision-making can be faulty, and control and process breakdowns can occur because of simple errors or mistakes, controls can be circumvented by individuals, acting alone or in collusion with each other, or by management override. The design of any system of controls is based in part on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected.
Our management assessed the effectiveness of our internal control over financial reporting as of June 27, 2026. In making this assessment, we used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”) of 2013 regarding Internal Control – Integrated Framework. Based on our assessment using those criteria, our management concluded that our internal control over financial reporting were not effective as of June 27, 2026. Management noted the following deficiencies that management believes to be material weaknesses:
| ● | The Company does not have a properly documented internal control system in accordance with the requirements of the Committee on Sponsoring Organizations (“COSO”) or some similarly appropriate internal control methodology or formal documentation of the Company’s systems of internal control. This control deficiency contributed to errors that necessitated a restatement of the Company’s 2024 consolidated financial statements and represents a material weakness in internal control over financial reporting. | |
| ● | The Company did not properly apply ASC 820 in valuing certain equity instruments issued as consideration in a business combination. The Company recorded and adjustment to correct the error. |
| 41 |
In response to the above identified weaknesses in our internal control over financial reporting, we plan to improve the documentation of our internal control policies and procedures and develop an internal testing plan to document our evaluation of effectiveness of the internal controls. We expect to conclude these remediation initiatives during the fiscal year ended December 26, 2026. We continue to evaluate testing of our internal control policies and procedures, including assessing internal and external resources that may be available to complete these tasks, but do not know when these tasks will be completed.
A material weakness (within the meaning of PCAOB Auditing Standard No. 5) is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis. A significant deficiency is a deficiency, or a combination of deficiencies, in internal control over financial reporting that is less severe than a material weakness, yet important enough to merit attention by those responsible for oversight of the company’s financial reporting.
| ● | The Company improperly recorded an adjustment that duplicated certain fees and overstated revenue. The Company recorded an adjustment to correct the error. | |
| ● | The Company used an incorrect grant-date fair value in measuring certain equity awards. The amount of the misstatement was not material. | |
| ● | The Company did not appropriately record certain qualifying equity issuance costs as a reduction of equity and instead recognized them in the income statement. The amount of the resulting misstatement was not material. |
This Quarterly Report does not include an attestation report of our registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by our registered public accounting firm pursuant to temporary rules of the SEC that permit us to provide only management’s report in this Quarterly Report.
Changes in Internal Control Over Financial Reporting. There were no changes in the Company’s internal control over financial reporting identified in management’s evaluation pursuant to Rule 13a-15and 15d-15 of the Exchange Act that occurred during the fiscal year ended June 27, 2026 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
| 42 |
PART II. Other Information
Item 1. Legal Proceedings
The information in response to this item is included in Note 15, Commitments and Contingencies, to the Consolidated Financial Statements included in Part I, Item 1, of this Form 10-Q.
Item 1A. Risk Factors
We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.
Item 2. Unregistered Sales of Equity Securities and Use of funds
None.
Item 3. Defaults Upon Senior Securities
None.
Item 4. Mine Safety Disclosures
None.
Item 5. Other Information.
None.
| 43 |
Item 6. Exhibits.
Index to Exhibits
* Filed herewith.
| 44 |
SIGNATURES
Pursuant to the requirements of Section 13 or Section 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on our behalf by the undersigned, thereunto duly authorized.
| AI Financial Corporation | |||
| (Registrant) | |||
| Date: | August 17, 2026 | By: | /s/ Tony Isaac |
| Tony Isaac | |||
| Chief Executive Officer | |||
| (Principal Executive Officer) | |||
| Date: | August 17, 2026 | By: | /s/Steven M. Plumb |
| Steven M. Plumb | |||
| Chief Financial Officer | |||
| (Principal Financial and Accounting Officer) | |||
| 45 |
Exhibit 10.127
ACQUISITION AGREEMENT
This Acquisition Agreement (this “Agreement”) is made and entered into as of July 29, 2026 (the “Agreement Date”), by and among AI Financial Corporation, a Nevada corporation (“AI Financial”), Alt 5 Sigma, Inc., a Delaware corporation and wholly-owned subsidiary of AI Financial (“Alt 5 Delaware”) (collectively, with AI Financial, the “Seller”), ALT5 Sigma Canada, Inc., a Quebec corporation and wholly-owned subsidiary of Alt 5 Delaware (“Alt 5 Canada”), Prime Delta Corp., a Delaware corporation (“Purchaser”), and, Paul Goodman (the “Series B Redemption Representative”), solely for the purposes of acting as the appointed representative of the holders1 of AI Financial Series B Preferred Stock (the “Series B Stock”).
WHEREAS, as of the date hereof, Alt 5 Delaware owns all of the issued and outstanding equity securities of Alt 5 Canada in the form of all of the issued and outstanding shares of the Company’s common stock (the “Alt 5 Canada Shares”);
WHEREAS, Alt 5 Delaware wishes to sell to Purchaser, and Purchaser wishes to purchase from Alt 5 Delaware, all of the Alt 5 Canada Shares, subject to the terms and conditions set forth herein (the “Acquisition”); and
WHEREAS, in connection with the Acquisition, AI Financial desires to attempt to use a portion of the Purchase Price Stock (as that term is defined in Section 1.2(c)) to redeem, on a consensual basis, all of the issued and outstanding shares of the Series B Stock;
NOW, THEREFORE, in consideration of the mutual covenants and agreements hereinafter set forth and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:
ARTICLE I – THE ACQUISITION
1.1 Purchase of Alt 5 Canada. Subject to the terms and conditions set forth herein, and in reliance upon the representations, warranties, and covenants contained in this Agreement, at the Closing, Alt 5 Delaware shall sell, transfer, and assign to Purchaser, and Purchaser shall acquire from Alt 5 Delaware, all of the Alt 5 Canada Shares, free and clear of all encumbrances, for the purchase price set forth hereinbelow (collectively, the “Purchase Price”).
1.2 Purchase Price. The aggregate value of the Purchase Price shall be deemed to be $23,551,750, to be paid at the Closing as follows:
| (a) | a four-year promissory note in the initial principal amount of $11,000,000, in the form attached hereto as Schedule A (the “Note”); and |
| (b) | a total of 11,551,750 newly issued shares of Purchaser’s common stock, $0.0001 par value per share (the “Purchase Price Stock”). |
| 1 | This appointment is subject, on a Series B stockholder-by-Series B stockholder basis, to the acceptance thereof by each respective holder of Series B Stock. |
| 1 |
1.3 The Closing. Subject to the terms and conditions of this Agreement, the closing of the transactions contemplated hereby shall take place remotely on July ___, 2026 (the “Closing”).
1. 4 Assignment of Trademark Rights and Goodwill (a) Effective as of the Closing, the Sellers hereby irrevocably assign, transfer, and convey to Purchaser, without further consideration, all of Sellers’ and each of their subsidiaries’ right, title, and interest, if any, in and to the all trademarks associated with “Alt 5” and “Alt 5 Sigma” (collectively, the “Alt 5 Marks”)2, together with all goodwill symbolized thereby and associated therewith, including all common law trademark rights, trade name rights, service mark rights, trade dress rights, domain names, social media identifiers, internet addresses, causes of action for past infringement and all other rights appurtenant thereto.
(b) Sellers acknowledge and agree that, as of the Closing, neither Seller nor any of their subsidiaries retains any ownership interest, license, or other right in the Alt 5 Marks except as expressly set forth in this Agreement, and no reservation of rights or implied license shall arise by operation of law or otherwise.
1.5 Transfer of Internet Assets. At Closing, Sellers shall assign to Purchaser all domain names, websites, social media accounts, usernames, and similar electronic assets incorporating the Alt 5 Marks. If any such asset cannot be transferred on the Closing Date due solely to technical or registrar requirements, Sellers shall hold such asset solely for Purchaser’s benefit, shall not use such asset except as Purchaser directs, and shall complete the transfer as soon as practicable.
1.6 Assistance in Consummation of the Acquisition. The parties shall provide all reasonable assistance to, and shall cooperate with, each other to bring about the consummation of the Acquisition as soon as possible in accordance with the terms and conditions of this Agreement.
1.7 Acknowledgment Regarding Post-Closing Operations. Purchaser acknowledges that, from and after the Closing, Alt 5 Canada shall continue to own its assets and remain solely responsible for its business and all of its debts, obligations, and liabilities, including its obligations to its employees, consultants, customers, suppliers, and other third parties. Except as expressly provided in this Agreement, Sellers shall have no responsibility or liability with respect to the operation of Alt 5 Canada or any such debts, obligations, or liabilities following the Closing.
| 2 | Except as may be required for historical or regulatory purposes, the Sellers will use their respective good faith efforts to change the corporate name of ALT5 Delaware and to change all e-mail addresses affiliated with any director, officer, employee, or consultant of either Seller from “xxx@alt5sigma.com” to an address that does not utilize the “alt5sigma.com” base. |
| 2 |
ARTICLE II – REPRESENTATIONS AND WARRANTIES
OF PURCHASER
Purchaser represents and warrants to Sellers as of the date of this Agreement and as of the Closing, all as follows in this Article II:
2.1 Organization, Good Standing. Purchaser is a corporation duly incorporated, validly existing, and in good standing under the laws of the State of Delaware, and has all requisite corporate power and authority to own, operate, and lease its properties and assets and to carry on its business as now conducted. Purchaser is duly qualified and licensed as a foreign corporation to do business and is in good standing in each jurisdiction where the character of Purchasers’ properties occupied, owned, or held under lease or the nature of the business conducted by Purchaser makes such qualification necessary.
2.2 Validly Issued. The shares of Purchase Price Stock to be issued in accordance with this Agreement, when issued and delivered in accordance with this Agreement, will be duly authorized and, when so issued and delivered as provided herein, will be validly issued, fully paid, and non-assessable, and will be free and clear of all liens created by Purchaser, other than restrictions on transfer arising under applicable federal and state securities laws or this Agreement.
2.3 No Approvals or Notices Required; No Conflicts With Instruments. The execution, delivery, and performance of this Agreement, the Note, and the Exchange Holder’s Release (collectively, the “Operative Documents”) by Purchaser and thereby will not (a) constitute a violation (with or without the giving of notice or lapse of time, or both) of any provision of law or any judgment, decree, order, regulation, or rule of any court or other governmental authority applicable to Purchaser, (b) require any consent, approval, or authorization of, or declaration, filing, or registration with, any person, corporation, partnership, joint venture, association, organization, other entity, or governmental or regulatory authority (a “Person”), (c) result in a default (with or without the giving of notice or lapse of time, or both) under, acceleration, or termination of, or the creation in any party of the right to accelerate, terminate, modify, or cancel, any agreement, lease, note, or other restriction, encumbrance, obligation, or liability to which Purchaser is a party or is bound or to which any of its assets is subject, (d) result in the creation of any lien or encumbrance upon the assets of Purchaser, (e) conflict with or result in a breach of or constitute a default under any provision of the Certificate of Incorporation or By-Laws of Purchaser, or (f) invalidate or adversely affect any permit, license, authorization, or status used in the conduct of the business of Purchaser.
2.4 Brokers and Finders. Purchaser represents and warrants that neither it nor any director, officer, agent, or employee acting on behalf of Purchaser has retained any broker or finder in connection with the transactions contemplated by this Agreement and the Operative Documents.
ARTICLE III – REPRESENTATIONS AND WARRANTIES
OF SELLER
Sellers represent and warrant to Purchaser, as of the date of this Agreement, all as follows in this Article III:
3.1 Organization; Good Standing. AI Financial is a corporation duly organized, validly existing, and in good standing under the laws of the State of Nevada, and has all requisite corporate power and authority to own, operate, and lease its properties and assets and to carry on its business as now conducted. Alt 5 Delaware is a corporation duly organized, validly existing, and in good standing under the laws of the State of Delaware, and has all requisite corporate power and authority to own, operate, and lease its properties and assets and to carry on its business as now conducted.
| 3 |
3.2 Authority. Each of AI Financial and Alt 5 Delaware has full corporate power and authority to execute, deliver, and perform this Agreement and the Operative Documents to which it is a party and to carry out the transactions contemplated hereby and thereby. This Agreement has been, and each Operative Document to which AI Financial or Alt 5 Delaware is a party will be, on the Closing Date, duly executed and delivered by AI Financial and Alt 5 Delaware and will be, on the Closing Date, a legal, valid, and binding obligation of AI Financial or Alt 5 Delaware, as applicable, enforceable against AI Financial or Alt 5 Delaware, as applicable in accordance with its terms.
3.3 No Approvals or Notices Required; No Conflicts With Instruments. The execution, delivery, and performance of this Agreement and the Operative Documents by Sellers are and the consummation of the transactions contemplated hereby and by the Operative Documents will not (a) constitute a violation (with or without the giving of notice or lapse of time, or both) of any provision of law or any judgment, decree, order, regulation, or rule of any court or other governmental authority applicable to Sellers, (b) require any consent, approval, or authorization of, or declaration, filing, or registration with, any Person, (c) result in a default (with or without the giving of notice or lapse of time, or both) under, acceleration, or termination of, or the creation in any party of the right to accelerate, terminate, modify, or cancel, any agreement, lease, note, or other restriction, encumbrance, obligation, or liability to which the relevant Seller is a party or by which either is bound or to which any of their assets are subject, (d) result in the creation of any material lien or encumbrance upon the assets of Sellers, (e) conflict with or result in a breach of or constitute a default under any provision of the charter documents of Sellers, or (f) invalidate or adversely affect any permit, license, authorization, or status used in the conduct of the business of Sellers.
ARTICLE IV – CONDITIONS PRECEDENT TO OBLIGATIONS
OF PURCHASER
The obligations of Purchaser to perform and observe the covenants, agreements, and conditions hereof to be performed and observed by it at or prior to the Closing Date shall be subject to the satisfaction of the following conditions on or prior to the Closing Date.
4.1 Accuracy of Representations and Warranties. The representations and warranties of Sellers contained herein and in the Operative Documents shall have been true in all material respects when made and shall be true as of the Closing Date as though made on that date, except as affected by transactions contemplated hereby and except to the extent that such representations and warranties are made as of a specified date, in which case such representations and warranties shall be true as of the specified date.
| 4 |
4.2 Performance of Agreement. Sellers shall have performed all obligations and agreements and complied with all covenants and conditions contained in this Agreement and in any Operative Document to be performed and complied with by it at or prior to the Closing Date.
ARTICLE V – CONDITIONS PRECEDENT TO OBLIGATIONS
OF SELLERS
The obligations of Sellers to perform and observe the covenants, agreements, and conditions hereof to be performed and observed by it at or prior to the Closing Date shall be subject to the satisfaction of the following conditions on or prior to the Closing Date.
5.1 Accuracy of Representations and Warranties. The representations and warranties of Purchaser contained herein and in the Operative Documents shall have been true when made and shall be true as of the Closing Date as though made on that date, except as affected by transactions contemplated hereby and except and to the extent that such representations and warranties are made as of a specified date, in which case such representations and warranties shall be true as of the specified date.
5.2 Performance of Agreement. Purchaser shall have performed all obligations and agreements and complied with all covenants and conditions contained in this Agreement or any Operative Document to be performed and complied with by it at or prior to the Closing Date.
ARTICLE VI – CONDITIONS PRECEDENT TO OBLIGATIONS OF ALL PARTIES
The obligations of all parties to perform and observe the covenants, agreements, and conditions hereof to be performed and observed by them at or prior to the Closing Date shall be subject to the satisfaction of the following conditions on or prior to the Closing Date, which conditions may be expressly waived in writing by AI Financial and Purchaser.
6.1 Legal Proceedings. No order of any court or administrative agency shall be in effect, which enjoins, restrains, conditions, or prohibits consummation of this Agreement or any Operative Document, and no litigation, investigation or administrative proceeding shall be pending or threatened which would enjoin, restrain, condition, or prevent consummation of this Agreement or any Operative Document.
6.2 Approvals and Consents. All transfers of permits or licenses, all approvals, applications, or notices to public agencies, federal, state, local, or foreign, the granting or delivery of which is necessary for the consummation of the transactions contemplated hereby shall have been obtained, and all waiting periods specified by law shall have passed. All other consents, approvals and notices referred to in this Agreement shall have been obtained or delivered.
| 5 |
ARTICLE VII – COVENANTS
7.1 Covenant to Discontinue Use. Except as set forth hereinabove, Sellers shall, and shall cause each of its respective subsidiaries to, permanently cease using the Alt 5 Marks, or any mark, name, or designation confusingly similar thereto, in any manner whatsoever, including as: (i) a corporate name, (ii) a trade name, (iii) a fictitious or assumed business name, (iv) a trademark or service mark, (v) a product or service name, (vi) a domain name, website address, or URL, (vii) an email address or email domain, (viii) a social media account or username, (ix) advertising, promotional or marketing material or (x) any other source identifier.
7.2 Change of Corporate Names. Except as set forth hereinabove, AI Financial shall cause each subsidiary whose legal name includes the term “Alt 5” or any confusingly similar designation to amend its organizational documents to adopt a name that does not include the Alt 5 Marks within ninety (90) calendar days following the Closing. Seller shall deliver to Purchaser copies of the filed certificates evidencing each such name change promptly after filing.
7.3 Future Use. Following the Closing and except as set forth hereinabove, neither AI Financial nor any subsidiary shall adopt, register, organize under, or use any name, mark, designation, or identifier containing the term “Alt 5,” Alt 5 Sigma,” or any confusingly similar designation in connection with any business. AI Financial shall not, directly or indirectly, (a) apply to register any trademark containing the Alt 5 Marks, (b) oppose any application filed by Purchaser relating to the Alt 5 Marks, (c) challenge Purchaser’s ownership of the Alt 5 Marks, or (d) assist any third party in taking any of the foregoing actions.
7.4 Mutual Releases.
(a) Purchaser, on behalf of itself, its subsidiaries, parent companies, predecessors, successors and assigns, and future, present, and former officers, directors, employees, consultants, agents, partners, stockholders, legal representatives, and its and their respective affiliates, and each and every one of them (collectively, the “Purchaser Releasing Parties”) hereby fully and unconditionally releases, absolves, acquits, and forever discharges each of AI Financial, its subsidiaries, its parent companies, and its affiliates (together, the “AI Financial Entities” and, individually, an “AI Financial Entity”) and all of each AI Financial Entity’s future, present, and former officers, directors, employees, agents, partners, stockholders, legal representatives, affiliates, parent companies, subsidiaries, members, managers, advisors, insurers, attorneys, consultants, successors, assigns, heirs, executors, administrators, and each and every one of them, and their predecessors, successors, and assigns, in their individual, as well as organizational capacities, in each case (collectively, the “AI Financial Group Members”), from any and all complaints, charges, claims, liabilities, demands, damages, fees, expenses, or other obligations, whether arising at law, by statute, or in equity, that have been brought, asserted, or alleged from the beginning of time through the date of this Agreement, or that have arisen, arise, or arise in the future in any way with respect to, relating to, or arising from, whether presently asserted or otherwise, whether known or unknown, whether suspected or unsuspected, whether foreseen or unforeseen, in each case, to the extent relating to or in connection with any matters, events, circumstances, actions, inactions, commissions, or omissions occurring, existing, or taken prior to date of this Agreement, in respect of matters relating to any AI Financial Entity. Purchaser on its own behalf and on behalf of each of the Purchaser Releasing Parties acknowledges that it is aware that it or they may hereafter discover facts different from or in addition to what it and they now know or believe to be true with respect to the matters herein released, and Purchaser on its own behalf and on behalf of each of the Purchaser Releasing Parties agrees that this release shall be and remain in effect in all respects as a complete release as to the matters released, notwithstanding any such different or additional facts. Purchaser intends this release to be a general release of any and all AI Financial Group Members to the fullest extent permissible by law. By signing this Agreement, Purchaser represents that neither it nor any other Purchaser Releasing Party has assigned any such claim to any third party. Nothing herein releases any rights of Purchaser to enforce the terms of this Agreement.
| 6 |
(b) AI Financial, on behalf of itself, its subsidiaries, parent companies, predecessors, successors and assigns, and future, present, and former officers, directors, employees, consultants, agents, partners, stockholders, legal representatives, and its and their respective affiliates, and each and every one of them (collectively, the “AI Financial Releasing Parties”) hereby fully and unconditionally releases, absolves, acquits, and forever discharges each of Purchaser, its subsidiaries, its parent companies, and its affiliates (together, the “Purchaser Entities” and, individually, a “Purchaser Entity”) and all of each Purchaser Entity’s future, present, and former officers, directors, employees, agents, partners, stockholders, legal representatives, affiliates, parent companies, subsidiaries, members, managers, advisors, insurers, attorneys, consultants, successors, assigns, heirs, executors, administrators, and each and every one of them, and their predecessors, successors, and assigns, in their individual, as well as organizational capacities, in each case (collectively, the “Purchaser Group Members”), from any and all complaints, charges, claims, liabilities, demands, damages, fees, expenses, or other obligations, whether arising at law, by statute, or in equity, that have been brought, asserted, or alleged from the beginning of time through the date of this Agreement, or that have arisen, arise, or arise in the future in any way with respect to, relating to, or arising from, whether presently asserted or otherwise, whether known or unknown, whether suspected or unsuspected, whether foreseen or unforeseen, in each case, to the extent relating to or in connection with any matters, events, circumstances, actions, inactions, commissions, or omissions occurring, existing, or taken prior to date of this Agreement, in respect of matters relating to any Purchaser Entity. AI Financial on its own behalf and on behalf of each of the AI Financial Releasing Parties acknowledges that it is aware that it or they may hereafter discover facts different from or in addition to what it and they now know or believe to be true with respect to the matters herein released, and AI Financial on its own behalf and on behalf of each of the AI Financial Releasing Parties agrees that this release shall be and remain in effect in all respects as a complete release as to the matters released, notwithstanding any such different or additional facts. Purchaser intends this release to be a general release of any and all Purchaser Group Members to the fullest extent permissible by law. By signing this Agreement, AI Financial represents that neither it nor any other AI Financial Releasing Party has assigned any such claim to any third party. Nothing herein releases any rights of AI Financial to enforce the terms of this Agreement.3
| 3 | Notwithstanding anything contained in this Section 7.4(b), the AI Financial Releasing Parties specifically do not release any of the Purchaser Entities from any events that occurred, or are alleged to have occurred, in Rwanda involving or allegedly involving ALT 5 Canada and any court proceedings in that country related thereto, including, but not limited to, The Higher Instance Court of Nyarugenge, located in Nyamirambo at its Headquarters, where it hears criminal procedure at the high instance level, including its public ruling in the cases known as: RP 01220/2023/TGI/NYGE, CMB RP 00384/2024/TGI/NYGE, and CMB RP/ECON 00102/2023/TGI/NYGE. |
| 7 |
7.5 Issuance of the Shares of Exchange Stock; Potential Redemption of Series B Preferred. At the Closing, Purchaser shall cause to be issued to AI Financial all of the shares of Purchase Price Stock to be vested in the name of AI Financial or otherwise in accordance with its issuance instructions. AI Financial and the Series B Redemption Representative hereby agree that, immediately following such issuance, AI Financial shall offer to the holders of the Series B Stock, through the Series B Redemption Representative, to redeem all of such holders’ shares of Series B Preferred Stock, on a pro rata basis, in exchange for a total of up to 8,551,750 shares of Purchase Price Stock( such shares of Purchase Price Stock to be potentially so exchanged, collectively, the “Exchange Stock”). Effective upon the Closing and the delivery of the shares of Redemption Stock to each of the holders of the Series B Preferred Stock, who choose to accept their pro rata shares of Exchange Stock, all of such redeemed shares of Series B Preferred Stock shall be cancelled and retired, shall cease to be issued and outstanding, and the holders thereof shall thereafter have no rights with respect thereto other than the right to receive the Exchange Stock, as provided herein. In connection with a holder of Series B Stock accepting the pro rata quantity of shares of Exchange Stock, such holder (an “Exchange Holder”) shall sign a release in the form attached hereto as Schedule B (an “Exchange Holder’s Release”). The Series B Redemption Representative hereby expressly acknowledges and agrees that he, without any input from AI Financial and without any attribution to AI Financial, shall convey such redemption/exchange offer to the holders of the Series B Stock, and, in connection therewith, shall provide to each of the holders of the Series B Stock such disclosure concerning Purchaser as is requested of him. The Series B Redemption Representative shall indemnify and hold AI Financial harmless from any and all claims from any holder of the Series B Stock in connection with the transactions contemplated by this Section 7.4. Any shares of Purchase Price Stock not so exchanged shall remain the property of AI Financial.
7.6 Cooperation. Each party hereto will fully cooperate with each other party and their respective counsel and accountants in connection with any steps required to be taken as part of its obligations under this Agreement. Each party will use its best efforts to cause all conditions to this Agreement to be satisfied as promptly as possible and to obtain all consents and approvals necessary for the due and punctual performance of this Agreement and for the satisfaction of the conditions hereof. No party will undertake any course of action inconsistent with this Agreement or that would make any representations, warranties, or agreements made by such party in this Agreement or any of the Operative Documents untrue or any conditions precedent to this Agreement unable to be satisfied at or prior to the Closing.
7.7 Further Acts. After the Closing Date, each party hereto, at the request of and without any further cost or expense to the other parties, will take any further actions necessary or desirable to carry out the purposes of this Agreement or any Operative Document.
7.8 Post-Closing Indemnity. From and after the Closing, Purchaser shall indemnify, defend and hold harmless AI Financial and its affiliates and their respective officers, directors, employees, agents and representatives from and against any and all Losses arising out of or relating to (i) the operation of Alt 5 Canada following the Closing, (ii) any acts or omissions of Purchaser or Alt 5 Canada occurring after the Closing, and (iii) any liabilities assumed by Purchaser under this Agreement.
| 8 |
7.9 Financial Information and Cooperation. From and after the Closing, each of Purchaser and Sellers shall, and shall cause their respective affiliates and representatives to, reasonably cooperate with the other and provide such books, records, work papers, information, and reasonable access to personnel as the other may reasonably request in connection with the preparation of financial statements, the completion of audits, reviews, or compilations, the preparation or filing of tax returns, reports, or other filings required by applicable Law or the rules and regulations of any governmental authority or securities exchange, or in connection with any accounting or financial reporting matters relating to periods prior to, on or including the Closing Date. Each party shall use commercially reasonable efforts to respond to such requests in a timely manner. The requesting party shall reimburse the other party for any reasonable out-of-pocket costs incurred in providing such assistance, excluding the cost of the responding party’s regular employees’ time unless the requested assistance requires a material commitment of such employees’ time or resources.
7.10 Non-Disparagement. (a) From and after the Closing, none of Purchaser or Sellers nor any of their respective Affiliates, nor any of their respective officers, directors, employees, or consultants acting on their respective behalf, shall knowingly make, publish, or authorize any false, misleading, or disparaging statement or communication, whether oral or written, that is intended to, or would reasonably be expected to, harm the reputation, business, or goodwill of the other party or any of its respective Affiliates, or their respective officers, directors, employees, or consultants.
(b) Notwithstanding the foregoing, nothing contained in this Section shall prohibit any party from: (a) making any statement or disclosure required by applicable Law, regulation, stock exchange rule, legal process, or order of any governmental authority; (b) making any statement or disclosure in any filing with the U.S. Securities and Exchange Commission or any other governmental authority or Self-Regulatory Authority, or any state or non-domestic securities regulatory agency; (c) making statements or disclosures reasonably necessary in connection with the enforcement of this Agreement or the prosecution or defense of any claim, action, or proceeding arising out of or relating to this Agreement or the transactions contemplated hereby; or (d) communicating with its legal counsel, accountants, auditors, insurers, financing sources, or other professional advisors, provided that such persons are subject to customary obligations of confidentiality.
7.11 Insurance Premium Refund. If, following the Closing, Alt 5 Canada receives any refund, rebate, or return of insurance premiums paid by or on behalf of Seller or Alt 5 Canada with respect to any period ending on or prior to the Closing Date, Purchaser shall cause Alt 5 Canada to remit such refund, rebate, or return to Seller within five (5) Business Days after receipt thereof, without offset or deduction.
ARTICLE VIII – TERMINATION
This Agreement may be terminated at any time prior to the Closing:
(a) by the mutual written consent of Purchaser and AI Financial;
(b) by either Purchaser or AI Financial if the Closing has not occurred by August 4, 2026.
In the event of any termination pursuant to this Article VIII (b), written notice thereof shall be given by the terminating party to the other party hereto. Such termination shall not prejudice any party’s right to seek remedies for another party’s breach of this Agreement.
| 9 |
ARTICLE IX – GENERAL
9.1 Expenses. Whether or not the transactions contemplated by this Agreement are consummated, each party shall pay its own fees and expenses incident to the negotiation, preparation, and carrying out of this Agreement and the Operative Documents (including legal and accounting fees and expenses), provided that, should any action be brought hereunder, the attorneys’ fees and expenses of the prevailing party shall be paid by the other party to such action.
9.2 Amendment. Purchaser and Seller may amend, modify, or supplement this Agreement at any time, but only in writing duly executed on behalf of each of the parties to be bound thereby.
9.3 Counterparts. This Agreement may be executed simultaneously in any number of counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.
9.4 Headings. The headings preceding the text of Articles and Sections of this Agreement are for convenience only and shall not be deemed parts thereof.
9.5 Applicable Law. This Agreement, including all matters of construction, validity, and performance, shall be governed by, and construed and enforced in accordance with, the laws of the State of Delaware, as applied to contracts executed and to be fully performed in such state by citizens of such state.
9.6 Parties in Interest. All the terms and provisions of this Agreement shall be binding upon and inure to the benefit of and be enforceable by the respective successors and permitted assigns of the parties hereto, whether herein so expressed or not, but neither this Agreement nor any of the rights, interests, or obligations hereunder of any party hereto shall be assigned without the prior written consent of each other party (which consent shall not be unreasonably withheld, delayed, denied, or conditioned). This Agreement is not intended, nor shall it be construed, to confer any enforceable rights on any person not a party hereto.
| 10 |
9.7 Notices. All notices, demands, requests, consents, approvals, and other communications required or permitted hereunder shall be in writing and, unless otherwise specified herein, shall be (a) personally served, (b) deposited in the mail, certified or registered, return receipt requested, postage prepaid, (c) delivered by reputable air courier service with charges prepaid, or (d) transmitted by e-mail, addressed as set forth below or to such other address as such party shall have specified most recently by written notice. Any notice or other communication required or permitted to be given hereunder shall be deemed effective (x) upon hand delivery or delivery by e-mail, with accurate confirmation generated by the transmitting computer, at the physical or e-mail address designated below (if delivered on a business day during normal business hours where such notice is to be received), or the first business day following such delivery (if delivered other than on a business day during normal business hours where such notice is to be received), (y) on the third business day following the date of transmittal by express courier service, fully prepaid, addressed to such address, or (z) upon actual receipt of such mailing, whichever shall first occur. The addresses for such communications shall be:
To Seller:
8548 Rozita Lee Avenue, Suite 305
Las Vegas, Nevada 89113
Attn: Tony Isaac, Chief Executive Officer
E-mail: t.isaac@isaac.com
with mandatory copies to
(which shall not constitute notice):
Clark Hill LLP
555 South Flower Street, 24th Floor
Los Angeles, California 90071
Attn: Randy Katz
E-mail: rkatz@clarkhill.com
To Purchaser:
Prime Delta Corp.
c/o Paul Goodman
Cyruli Shanks & Zizmor, LLP
420 Lexington Avenue; Suite 2320
New York, New York 10170
E-mail: pgoodman@cszlaw.com
To the Series B Redemption Representative:
Paul Goodman
c/o Cyruli Shanks & Zizmor, LLP
420 Lexington Avenue; Suite 2320
New York, New York 10170
E-mail: pgoodman@cszlaw.com
(*** Signatures on following page ***)
| 11 |
IN WITNESS WHEREOF, the parties hereto have entered into and signed this Agreement as of the date and year first above written.
| AI FINANCIAL CORPORATION | ||
| By | ||
| Tony Isaac | ||
| Its Chief Executive Officer | ||
| ALT 5 SIGMA, INC. | ||
| By: | ____________________________________________ | |
| Tony Isaac | ||
| Chief Executive Officer | ||
| PRIME DELTA CORP. | ||
| By: | ____________________________________________ | |
| PAUL GOODMAN | ||
| solely as Series B Redemption Representative | ||
| 12 |
SCHEDULE A
THIS NOTE MAY NOT BE VOLUNTARY TRANSFERRED, SOLD, PLEDGED, HYPOTHECATED, OR OTHERWISE DISPOSED OF UNLESS (I)(A) SUCH TRANSFER OR OTHER DISPOSITION IS COVERED BY A REGISTRATION STATEMENT EFFECTIVE UNDER THE SECURITIES ACT OF 1933 OR (B) IN THE OPINION OF COUNSEL SATISFACTORY TO THE CORPORATION, SUCH TRANSFER OR OTHER DISPOSITION IS EXEMPT FROM THE REGISTRATION REQUIREMENTS OF SECTION 5 OF THAT ACT OR (C) A NO-ACTION LETTER FROM THE SECURITIES AND EXCHANGE COMMISSION SATISFACTORY TO COUNSEL TO THE CORPORATION SHALL HAVE BEEN OBTAINED WITH RESPECT TO SUCH TRANSFER OR OTHER DISPOSITION AND (II) SUCH TRANSFER OR OTHER DISPOSITION IS MADE IN COMPLIANCE WITH APPLICABLE STATE SECURITIES LAWS.
SECURED PROMISSORY NOTE
PRIME DELTA CORP.,
a Delaware corporation
| $12,000,000.00 | July 29, 2024 |
| Las Vegas, Nevada |
PRIME DELTA CORP., a corporation duly organized and existing under the laws of the State of Delaware (the “Company”), for value received, hereby promises to pay to AI Financial Corporation (the “Holder”), upon presentation and surrender of this Promissory Note (the “Note”) at the principal office of the Holder the principal amount of this Note and accrued and unpaid interest thereon, in the lawful currency of the United States of America.
1. Principal Amount and Term. This Note, in the principal amount of $12,000,000.00 (the “Principal Amount”), is issued and dated as of the date set forth above, and is due and payable as set forth below.
2. Interest. Interest will accrue on the Principal Amount outstanding from time to time at the rate of four percent (4%) per annum, until the Principal Amount is repaid in full. Interest will be payable within the tenth day of each calendar month commencing August 10, 2026. Interest will be calculated on the basis of a 360-day year.
3. Repayment. A. In addition to the payment of interest, as set forth in Section 2, above, the Company shall make payments of the Principal Amount to Holder as follows: (a) the amount of $1,000,000 on or before August 11, 2026, and then (b) four (4) equal annual payments in the amount of $2,750,000, paid on each anniversary of this Note. In the event that, at the time that any payment is due hereunder, the Company’s common stock (or that of a successor-in-interest through a merger, reverse merger, business combination transaction, or similar event) is listed on Nasdaq or another national exchange, the Company shall promptly provide notice thereof to the Holder, which shall have the option from and after such time to require any or all payments of principal and interest (on a payment-by-payment basis) and, unless the Company shall then be in default (in which case, the provisions of Section 4, below, may, at the sole option of the Holder, supersede the potential “payment-in-stock” provisions of this Section), the Company may demand that all otherwise then-unaccrued payment obligations hereunder be accelerated to be paid in cash or in the form of newly issued shares of the Company’s (or such successor’s) common stock, to be valued at ninety percent (90%) of the volume weighted average price of the Company’s common stock for the ten (10) trading days prior to the date on which the Holder has exercised such “payment-in-stock” option. The parties agree that, for purposes of Rule 144, the holding period shall be deemed to have commended on the date of this Note, and not on the date on which any payments hereunder are tendered in the form of newly issued shares of common stock.
| 1 |
B. Notwithstanding anything to the contrary contained in Section 4A above, in the event that the Company receives equity investments from third party investors, no less than twenty percent (20%) of the net amount received from investors shall be paid to Holder as a payment of outstanding principal and interest and such amounts shall be credited against the payments required under Section 4A(a) and 4A(b) above.
4. Default. In the event that (a) the Company fails to make any payment of interest or Principal Amount hereunder when due and does not cure such failure within ten (10) calendar days after receipt by the Company of written notice of such failure from the Holder, (b) the Company attempts to assign any or all of its duties or obligations hereunder, in whole or in part without the prior written consent of the Holder (which consent shall not be unreasonably withheld, delayed, denied, or conditioned), (c) a change of control of the Company and any of its subsidiaries (e.g., ALT5 Sigma Canada, Inc., a Quebec corporation), whether or not through the consummation of any merger, reverse merger, or business combination involving the Company and any of its subsidiaries or other affiliates or any acquisition of any or all of the assets of one or more of such entities, outside of the ordinary course of busines, or (d) the Company shall: (i) apply for or consent to the appointment of a receiver, trustee, custodian, or liquidator of it or any of its properties; (ii) admit in writing its inability to pay its debts as they mature; (iii) make a general assignment for the benefit of creditors; (iv) be adjudicated a bankrupt or insolvent or be the subject of an order for relief under Title 11 of the United States Code or any bankruptcy, reorganization, insolvency, readjustment of debt, dissolution, or liquidation law or statute of any other jurisdiction or foreign country; (v) file a voluntary petition in bankruptcy, or a petition or an answer seeking reorganization or an arrangement with creditors or to take advantage or any bankruptcy, reorganization, insolvency, readjustment of debt, dissolution, or liquidation law or statute, or an answer admitting the material allegations of a petition filed against it in any proceeding under any such law, or (vi) take or permit to be taken any action in furtherance of or for the purpose of effecting any of the foregoing, then, in any such case, all then-outstanding Principal Amount of and accrued interest on this Note may be declared due and payable by the Holder, and upon such declaration shall thereupon become due and payable. Notwithstanding anything to the contrary set forth in this Note, the consummation by the Company of a merger, reverse merger, or business combination through a de-SPAC transaction to which the Company is the counter-party to the public entity shall, by itself, constitute an exception from the provisions of this Section 4(c).
| 2 |
5. Prepayment. The Company may prepay the Principal Amount outstanding in whole or in part at any time or from time to time without penalty provided that the Company pays all accrued but unpaid interest on such prepayment therewith. Any partial prepayment of the Principal Amount shall be applied first to the final annual payment of Principal Amount due hereunder, second to the penultimate annual payment of Principal Amount due hereunder, and so on.
6. Security Agreement. This Secured Promissory Note is secured pursuant to a Security Agreement, dated of even date hereof by the Company in favor of and Holder.
7. Corporate Obligations. No provision of this Note shall alter or impair the obligation of the Company, which is absolute and unconditional, to pay the Principal Amount of and interest on this Note at the times, place, herein prescribed, except in the event of a redemption of all or part of this Note as herein provided. No recourse under or upon any obligation, covenant, or agreement contained in this Note, or for any claim based thereon or otherwise in respect thereof, shall be had against any promoter, subscriber to shares, incorporator, shareholder, officer, or director, as such, past, present, or future, of the Company or of any successor corporation, either directly or through the Company or any successor corporation or through any trustee, receiver, or any other person, whether by virtue of any constitution, statute, or rule of law, or by the enforcement of any assessment or penalty or otherwise; it being expressly understood that this Note is solely a corporate obligation of the Company, and that any and all such personal liability, either at common law or in equity or by constitution or statute or rule of law, and any and all such rights and claims against, every such promoter, subscriber, incorporator, shareholder, officer, or director, as such, are hereby expressly waived and released by the holder by the acceptance of this Note and as a part of the consideration for the issue hereof.
8. Compliance with Securities Laws. The Holder acknowledges that this Note is being acquired solely for the Holder’s own account and not as a nominee for any other party, and for investment, and that the Holder will not offer, sell or otherwise dispose of this Note except pursuant to an effective registration statement, or an exemption from registration, under the Securities Act of 1933, as amended (the “Securities Act”), and any applicable state securities laws.
9. Miscellaneous. (a) In addition to and not in limitation of the foregoing, the Company further agrees, subject only to any limitation imposed by applicable law, to pay all expenses, included, but not limited to, attorneys’ fees and legal expenses incurred by the Holder in connection with the administration of this Note or collection hereof.
(b) None of the provisions of this Note may be waived, changed, or terminated orally or otherwise, except by a writing duly executed by the Company and the Holder. This Note shall be governed by and construed in accordance with the laws of Delaware. The sole jurisdiction for any disputes concerning this Note or attempt to enforce this Note shall be brought in a Court of appropriate jurisdiction within the State of Delaware.
(c) This Note shall be binding upon and inure to the benefit of the parties hereto and their respective successors and permitted assigns. In the event any one or more of the provisions contained in this Note for any reason be held to be invalid, illegal, or unenforceable in any respect, such invalidity, illegality, or unenforceability shall not affect any other provision of this Note or such other security documents; but, this Note shall be construed as if such invalid, illegal, or unenforceable provision had never been contained herein or therein.
(d) IN ANY ACTION, SUIT, OR PROCEEDING IN RESPECT OR ARISING OUT OF THIS NOTE, THE HOLDER WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT TO A TRIAL BY JURY AS WELL AS ANY CLAIM FOR CONSEQUENTIAL, PUNITIVE, OR SPECIAL DAMAGES.
| 3 |
IN WITNESS WHEREOF, the Company has caused this Note to be duly executed under its corporate seal by the signature of its authorized officer, as of the __ day of July, 2026.
| PRIME DELTA CORP. | ||||
| By: | ||||
| , Chief Executive Officer | ||||
| Accepted By Holder: | ||||
| AI FINANCIAL CORPORATION | ||||
| By: | ||||
| Tony Isaac, Chief Executive Officer | ||||
| 4 |
SCHEDULE B
Ladies and Gentlemen:
Let me introduce myself: my name is Paul Goodman. With your approval, I will be serving as your designated “Series B Redemption Representative.” I am sending this Information Letter to you and each other record holder of Series B Preferred Stock (the “Series B Preferred”) of AI Financial Corporation (“AIFC”; formerly Alt5 Sigma Corporation, formerly JanOne Corp).
Alt 5 Sigma Canada, Inc. (“Alt 5 Sigma Canada”), has been purchased by Prime Delta Corp. (“Prime Delta”), a company formed by certain founders of Alt 5 Sigma, Inc., a Delaware corporation that was a subsidiary of AIFC and was the owner of Alt 5 Sigma Canada (the “Alt 5 Sigma Canada Acquisition”). You were issued shares of AIFC common stock and shares of AIFC Series B Preferred when AIFC purchased Alt 5. As you may be aware, the Series B Preferred was never convertible into shares of AIFC and holders of Series B Preferred never had any right to have their shares redeemed.
In connection with the Alt 5 Sigma Canada Acquisition, Prime Delta issued shares of its common stock (“Prime Delta Common Stock”) to AIFC and AIFC, through my office, is presenting you and the other holders of Series B Preferred with an offer to exchange your Series B Preferred for shares of Prime Delta Common Stock on a one-for-one basis (the “Redemption/Exchange Offer”). Technically, if you accept the Redemption/Exchange Offer, your shares of Series B Preferred with be redeemed by AIFC, the redemption payment for which will be AIFC’s distribution to you, through my office, of certain of the shares of Prime Delta Common Stock that AIFC received in connection with the Alt 5 Sigma Canada Acquisition. You should discuss any tax implications for your acceptance of this Redemption/Exchange Offer with your tax advisor. It is my hope, as your potential Series B Redemption Representative, that your acceptance of this Redemption/Exchange Offer will provide you and the other holders of Series B Preferred, who accept this Redemption/Exchange Offer, with a pathway to liquidity within the next 12 months. Of course, there can be no guarantees that your acceptance of the Redemption/Exchange Offer and the consummation of the redemption/exchange will provide any liquidity for you at any time. You should also be aware that, before any redemptions/exchanges take place, approximately [1/3] of the Series B Preferred is held of record by the holders of Prime Delta Common Stock, many of whom were also the founders of Alt 5.
If you choose to exchange your shares of Series B Preferred for shares of Prime Delta Common Stock, I would ask that you sign and return the attached Letter of Transmittal. If you would like any information concerning Prime Delta as you come to a determination whether (i) to accept my appointment as your Series B Redemption Representative and (ii) thereafter, to accept the Redemption/Exchange Offer, please feel free to send me an e-mail with whatever questions or requests for information you would like. I will try to respond promptly to your inquiries before you decide whether (i) to accept my appointment as your Series B Redemption Representative and (ii) to accept the Redemption/Exchange Offer. My e-mail address is: pgoodman@cszlaw.com.
Please read the accompanying Instructions carefully and then, if you choose (i) to accept my appointment as your Series B Redemption Representative and (ii) to accept the Redemption/Exchange Offer, complete and return all pages of this Letter of Transmittal (to the extent applicable) and any other required tax materials to me by [●], 2026) ,as provided for below.
Delivery may be made (a) by e-mail, (b) through the online portal (as described in the accompanying instructions provided with this Letter of Transmittal), or (c) by (i) hand delivery, (ii) registered mail, or (iii) overnight delivery by means of a reputable courier. Please retain a copy of this Letter of Transmittal and any other required tax materials for your records.
Thank you,
PAUL GOODMAN
Letter of Transmittal
Paul Goodman, Esq.
Cyruli Shanks & Zizmor, LLP
420 Lexington Avenue, Suite 2320
New York, New York 10170
E-mail: pgoodman@cszlaw.com
AIFC Series B Preferred and Prime Delta Common Stock Redemption/Exchange Offer
Dear Mr. Goodman:
I hereby accept your appointment as my Series B Redemption Representative in connection with the Exchange Offer referenced in your correspondence to me dated July [*], 2026.
In connection with the Alt 5 Sigma Canada Acquisition, the undersigned hereby surrenders for redemption the below-described shares of AI Financial Corporation (“AIFC”) Series B Preferred Stock (the “Series B Preferred Stock”) in exchange for an equal number of shares of Price Delta Common Stock.
The undersigned hereby represents and warrants that the undersigned (i) owns beneficially and of record all of the Series B Preferred Stock that the undersigned has chosen to redeem, as indicated below, free and clear of all liens, restrictions, charges, and encumbrances, and the same, in each case, will not be subject to any adverse claims and (ii) has full power and authority to assign and transfer the Series B Preferred Stock to AIFC and such assignment and transfer will not conflict or violate any organizational document or agreement, contract, instrument, or commitment of the undersigned or any law, statute, ordinance, regulation, rule, judgment, order, writ, injunction, or decree binding upon or applicable to the undersigned.
The undersigned will, upon request, execute and deliver any additional documents necessary or desirable to complete the redemption and the exchange, at the sole cost and expense of the requesting party(ies). All authority herein conferred or agreed to be conferred to Paul Goodman, as the Series B Redemption Representative, shall survive the death or incapacity of the undersigned, and any obligation of the undersigned hereunder shall be binding on the heirs, executors, administrators, personal representatives, trustees in bankruptcy, successors, and assigns of the undersigned.
Effective as of my delivery of this Letter of Transmittal, I, on my own behalf and on behalf of my heirs, family members, successors, assigns, executors, subsidiaries, parent entities, and each of their respective affiliates, and each of their respective successors and assigns, and any present or former directors, managers, partners, officers, employees or agents of such person or entity (each, a “Releasing Party”), hereby unconditionally and irrevocably and forever release and discharge each of AI Financial Corporation, Prime Delta Corp., the Series B Redemption Representative, and each of their respective affiliates, and each of their respective successors and assigns, and any present or former directors, managers, partners, officers, employees, or agents of such person or entity (each, a “Released Party”), of and from, and hereby unconditionally and irrevocably waive, any and all claims, debts, losses, expenses, proceedings, covenants, liabilities, suits, judgments, damages, actions, and causes of action, obligations, accounts, and liabilities of any kind or character whatsoever, known or unknown, suspected or unsuspected, in contract, direct or indirect, at law or in equity that such party ever had, now has or ever may have or claim to have against any Released Party, for or by reason of any matter, circumstance, event, action, inaction, omission, cause, or thing whatsoever arising prior to the redemption or exchange transaction described in this Letter of Transmittal. I expressly waive all rights afforded by any statute which limits the effect of a release with respect to unknown claims. I understand the significance of this release of unknown claims and waiver of statutory protection against a release of unknown claims. I have had the opportunity to obtain counsel of my choosing in respect of the transactions contemplated by this Letter of Transmittal.
Number of shares of Series B Stock being redeemed:___________________________
Number of shares of Prime Delta Common Stock being received in exchange:_______________
Agreed to by:
___________________________________
Exhibit 10.128
THIS NOTE MAY NOT BE VOLUNTARY TRANSFERRED, SOLD, PLEDGED, HYPOTHECATED, OR OTHERWISE DISPOSED OF UNLESS (I)(A) SUCH TRANSFER OR OTHER DISPOSITION IS COVERED BY A REGISTRATION STATEMENT EFFECTIVE UNDER THE SECURITIES ACT OF 1933 OR (B) IN THE OPINION OF COUNSEL SATISFACTORY TO THE CORPORATION, SUCH TRANSFER OR OTHER DISPOSITION IS EXEMPT FROM THE REGISTRATION REQUIREMENTS OF SECTION 5 OF THAT ACT OR (C) A NO-ACTION LETTER FROM THE SECURITIES AND EXCHANGE COMMISSION SATISFACTORY TO COUNSEL TO THE CORPORATION SHALL HAVE BEEN OBTAINED WITH RESPECT TO SUCH TRANSFER OR OTHER DISPOSITION AND (II) SUCH TRANSFER OR OTHER DISPOSITION IS MADE IN COMPLIANCE WITH APPLICABLE STATE SECURITIES LAWS.
SECURED PROMISSORY NOTE
PRIME DELTA CORP.,
a Delaware corporation
| $12,000,000.00 | July 29, 2024 |
Las Vegas, Nevada
PRIME DELTA CORP., a corporation duly organized and existing under the laws of the State of Delaware (the “Company”), for value received, hereby promises to pay to AI Financial Corporation (the “Holder”), upon presentation and surrender of this Promissory Note (the “Note”) at the principal office of the Holder the principal amount of this Note and accrued and unpaid interest thereon, in the lawful currency of the United States of America.
1. Principal Amount and Term. This Note, in the principal amount of $12,000,000.00 (the “Principal Amount”), is issued and dated as of the date set forth above, and is due and payable as set forth below.
2. Interest. Interest will accrue on the Principal Amount outstanding from time to time at the rate of four percent (4%) per annum, until the Principal Amount is repaid in full. Interest will be payable within the tenth day of each calendar month commencing August 10, 2026. Interest will be calculated on the basis of a 360-day year.
| 1 |
3. Repayment. A. In addition to the payment of interest, as set forth in Section 2, above, the Company shall make payments of the Principal Amount to Holder as follows: (a) the amount of $1,000,000 on or before August 11, 2026, and then (b) four (4) equal annual payments in the amount of $2,750,000, paid on each anniversary of this Note. In the event that, at the time that any payment is due hereunder, the Company’s common stock (or that of a successor-in-interest through a merger, reverse merger, business combination transaction, or similar event) is listed on Nasdaq or another national exchange, the Company shall promptly provide notice thereof to the Holder, which shall have the option from and after such time to require any or all payments of principal and interest (on a payment-by-payment basis) and, unless the Company shall then be in default (in which case, the provisions of Section 4, below, may, at the sole option of the Holder, supersede the potential “payment-in-stock” provisions of this Section), the Company may demand that all otherwise then-unaccrued payment obligations hereunder be accelerated to be paid in cash or in the form of newly issued shares of the Company’s (or such successor’s) common stock, to be valued at ninety percent (90%) of the volume weighted average price of the Company’s common stock for the ten (10) trading days prior to the date on which the Holder has exercised such “payment-in-stock” option. The parties agree that, for purposes of Rule 144, the holding period shall be deemed to have commended on the date of this Note, and not on the date on which any payments hereunder are tendered in the form of newly issued shares of common stock.
B. Notwithstanding anything to the contrary contained in Section 4A above, in the event that the Company receives equity investments from third party investors, no less than twenty percent (20%) of the net amount received from investors shall be paid to Holder as a payment of outstanding principal and interest and such amounts shall be credited against the payments required under Section 4A(a) and 4A(b) above.
4. Default. In the event that (a) the Company fails to make any payment of interest or Principal Amount hereunder when due and does not cure such failure within ten (10) calendar days after receipt by the Company of written notice of such failure from the Holder, (b) the Company attempts to assign any or all of its duties or obligations hereunder, in whole or in part without the prior written consent of the Holder (which consent shall not be unreasonably withheld, delayed, denied, or conditioned), (c) a change of control of the Company and any of its subsidiaries (e.g., ALT5 Sigma Canada, Inc., a Quebec corporation), whether or not through the consummation of any merger, reverse merger, or business combination involving the Company and any of its subsidiaries or other affiliates or any acquisition of any or all of the assets of one or more of such entities, outside of the ordinary course of busines, or (d) the Company shall: (i) apply for or consent to the appointment of a receiver, trustee, custodian, or liquidator of it or any of its properties; (ii) admit in writing its inability to pay its debts as they mature; (iii) make a general assignment for the benefit of creditors; (iv) be adjudicated a bankrupt or insolvent or be the subject of an order for relief under Title 11 of the United States Code or any bankruptcy, reorganization, insolvency, readjustment of debt, dissolution, or liquidation law or statute of any other jurisdiction or foreign country; (v) file a voluntary petition in bankruptcy, or a petition or an answer seeking reorganization or an arrangement with creditors or to take advantage or any bankruptcy, reorganization, insolvency, readjustment of debt, dissolution, or liquidation law or statute, or an answer admitting the material allegations of a petition filed against it in any proceeding under any such law, or (vi) take or permit to be taken any action in furtherance of or for the purpose of effecting any of the foregoing, then, in any such case, all then-outstanding Principal Amount of and accrued interest on this Note may be declared due and payable by the Holder, and upon such declaration shall thereupon become due and payable. Notwithstanding anything to the contrary set forth in this Note, the consummation by the Company of a merger, reverse merger, or business combination through a de-SPAC transaction to which the Company is the counter-party to the public entity shall, by itself, constitute an exception from the provisions of this Section 4(c).
5. Prepayment. The Company may prepay the Principal Amount outstanding in whole or in part at any time or from time to time without penalty provided that the Company pays all accrued but unpaid interest on such prepayment therewith. Any partial prepayment of the Principal Amount shall be applied first to the final annual payment of Principal Amount due hereunder, second to the penultimate annual payment of Principal Amount due hereunder, and so on.
| 2 |
6. Security Agreement. This Secured Promissory Note is secured pursuant to a Security Agreement, dated of even date hereof by the Company in favor of and Holder.
7. Corporate Obligations. No provision of this Note shall alter or impair the obligation of the Company, which is absolute and unconditional, to pay the Principal Amount of and interest on this Note at the times, place, herein prescribed, except in the event of a redemption of all or part of this Note as herein provided. No recourse under or upon any obligation, covenant, or agreement contained in this Note, or for any claim based thereon or otherwise in respect thereof, shall be had against any promoter, subscriber to shares, incorporator, shareholder, officer, or director, as such, past, present, or future, of the Company or of any successor corporation, either directly or through the Company or any successor corporation or through any trustee, receiver, or any other person, whether by virtue of any constitution, statute, or rule of law, or by the enforcement of any assessment or penalty or otherwise; it being expressly understood that this Note is solely a corporate obligation of the Company, and that any and all such personal liability, either at common law or in equity or by constitution or statute or rule of law, and any and all such rights and claims against, every such promoter, subscriber, incorporator, shareholder, officer, or director, as such, are hereby expressly waived and released by the holder by the acceptance of this Note and as a part of the consideration for the issue hereof.
8. Compliance with Securities Laws. The Holder acknowledges that this Note is being acquired solely for the Holder’s own account and not as a nominee for any other party, and for investment, and that the Holder will not offer, sell or otherwise dispose of this Note except pursuant to an effective registration statement, or an exemption from registration, under the Securities Act of 1933, as amended (the “Securities Act”), and any applicable state securities laws.
9. Miscellaneous. (a) In addition to and not in limitation of the foregoing, the Company further agrees, subject only to any limitation imposed by applicable law, to pay all expenses, included, but not limited to, attorneys’ fees and legal expenses incurred by the Holder in connection with the administration of this Note or collection hereof.
(b) None of the provisions of this Note may be waived, changed, or terminated orally or otherwise, except by a writing duly executed by the Company and the Holder. This Note shall be governed by and construed in accordance with the laws of Delaware. The sole jurisdiction for any disputes concerning this Note or attempt to enforce this Note shall be brought in a Court of appropriate jurisdiction within the State of Delaware.
(c) This Note shall be binding upon and inure to the benefit of the parties hereto and their respective successors and permitted assigns. In the event any one or more of the provisions contained in this Note for any reason be held to be invalid, illegal, or unenforceable in any respect, such invalidity, illegality, or unenforceability shall not affect any other provision of this Note or such other security documents; but, this Note shall be construed as if such invalid, illegal, or unenforceable provision had never been contained herein or therein.
(d) IN ANY ACTION, SUIT, OR PROCEEDING IN RESPECT OR ARISING OUT OF THIS NOTE, THE HOLDER WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT TO A TRIAL BY JURY AS WELL AS ANY CLAIM FOR CONSEQUENTIAL, PUNITIVE, OR SPECIAL DAMAGES.
| 3 |
IN WITNESS WHEREOF, the Company has caused this Note to be duly executed under its corporate seal by the signature of its authorized officer, as of the __ day of July, 2026.
| PRIME DELTA CORP. | ||
| By: | ||
| , Chief Executive Officer | ||
| Accepted By Holder: | ||
| AI FINANCIAL CORPORATION | ||
| By: | ||
| Tony Isaac, Chief Executive Officer | ||
| 4 |
Exhibit 10.129
SECURITY AGREEMENT
THIS SECURITY AGREEMENT (the “Agreement”) is being made and entered into as of July 28, 2026, by and between Prime Delta Corp., a Delaware corporation with principal place of business at 140 Wall Street, 20th Floor, New York, NY 10005 (“Debtor”) and AI Financial Corporation, a Nevada corporation having its principal place of business at 8548 Rozita Lee Avenue, Suite 305, Las Vegas, Nevada 89113 (“Secured Party “).
W I T N E S S E T H:
WHEREAS, pursuant to that certain Secured Convertible Promissory Note of even date herewith executed by Debtor in favor of the Secured Party (the “Note”), Debtor has become indebted to the Secured Party for the aggregate principal sum of Eleven Million Dollars ($11,000,000.00); and
WHEREAS, as collateral for its obligations under the Note (the “Obligations”), Secured Party requires that Debtor grant to Secured Party, a first priority senior security interest in all of its assets and property; and
WHEREAS, Debtor and Secured Party desire that this Agreement shall set forth their full and complete understanding regarding the terms and conditions under which Debtor will grant Secured Party a security interest in all of its assets and property.
NOW, THEREFORE, FOR AND IN CONSIDERATION of the premises, the mutual promises and covenants herein contained, and other good and valuable consideration, the receipt, sufficiency, and adequacy of which are expressly acknowledged, Debtor and Secured Party, each intending to be legally bound, do hereby mutually agree as follows:
1. Grant of Security Interest.
As security for the prompt and complete payment and performance when due of all of the Obligations, as hereinafter defined, Debtor does hereby grant to Secured Party a continuing first priority security interest (“Security Interest”) in all personal property, assets and fixtures of Debtor, wherever located, whether now existing or owned or hereafter arising or acquired, whether or not subject to the Uniform Commercial Code, as the same may be in effect in the State of Delaware, as amended from time to time (“UCC”), and whether or not affixed to any realty, including, without limitation, (i) all inventory, accounts, chattel paper, investment property, deposit accounts, documents, goods, equipment, products, websites, URL’s. customer, member and supplier lists and records, general intangibles (including proprietary software in any stage of development, websites, domain names, trademarks, service marks, trade names, patents, copyrights, licenses and franchises), instruments, inventory, money, accounts receivable, letter of credit rights, causes of action (including tort claims), and other personal property (including agreements and instruments not constituting chattel paper or a document, general intangible or instrument); (ii) all additions to, accessions to, substitutions for, replacements of and supporting obligations of the foregoing; (iii) all proceeds and products of the foregoing, including, without limitation, insurance proceeds; and (iv) all business records and information relating to any of the foregoing and any software or other programs for accessing and manipulating such information (collectively, the “Collateral”). Debtor acknowledges and agrees that the foregoing collateral description is intended to cover all assets of Debtor, whether now owned or hereafter acquired, and all proceeds arising therefrom.
| 1 |
2. Obligations Secured.
The security interest granted by Debtor to Secured Party in the Collateral and evidenced hereby shall secure the Debtor’s Obligations, including full repayment of the Note plus interest and other items potentially owing thereunder.
3. Representations, Warranties, and Covenants of Debtor.
As an inducement to Secured Party to make the loans, advances, and extensions of credit to Debtor which are secured hereby, Debtor hereby represents, warrants, and covenants to Secured Party as follows:
(a) Except for the security interest granted pursuant to this Agreement, Debtor now owns the Collateral, free and clear of any and all liens, claims, charges, security interests, and other encumbrances of every type, kind, or nature. Debtor will defend the Collateral and Secured Party’s security interest in the same against any and all claims and demands of any person or persons who at any time claim any ownership or other interest therein;
(b) Debtor authorizes Secured Party to file all such Uniform Commercial Code Financing Statements as Secured Party may require to perfect Secured Party’s security interest in the Collateral and protect the same against the claims of third parties. No other financing statement has been filed or recorded which includes the Collateral or the proceeds of the Collateral, in whole or in part, within its collateral description;
(c) Debtor shall promptly deliver to Secured Party all of the certificates representing the shares of equity owned by Debtor, whether of record or beneficially;
(d) During the term of this Agreement, Debtor will not grant or suffer the existence of any lien, claim, charge, security interest or other encumbrance of any type, kind, or nature with respect to the Collateral, without the prior written consent of the Secured Party and will, at all times, maintain good and merchantable title with respect to the same;
(e) Debtor will cause the Collateral to be insured with companies who are acceptable to the Secured Party, which insurance policies: (i) shall have such coverage provisions, policy limits and exclusions as Secured Party shall require; (ii) shall name Secured Party as an additional insured and/or loss payee thereunder, as its interests may appear; (iii) shall require at least thirty (30) days’ prior written notice to Secured Party of any intended cancellation, modification, termination, or expiration of the policy or policies evidencing such insurance. Debtor will deliver such certificates of insurance and other evidence of insurance coverage as Secured Party may require;
| 2 |
(f) At all times during the term of this Agreement, and except as otherwise provided herein, Debtor: (i) shall keep and maintain the Collateral in good and usable condition, free and clear of any and all liens, claims, charges and security interests of every type, kind or nature; (ii) will promptly pay all taxes, assessments and other charges with respect to the Collateral; (iii) will not use the Collateral illegally or in violation of any Agreement between Debtor and any third party; and (iv) will not transfer, convey, assign, sell or otherwise dispose of any portion of the Collateral, except in the ordinary course of its business.
4. Performance of Obligations by Secured Party.
In the event that Debtor fails to perform or comply with the terms of any duty, obligation, representation, warranty or covenant herein contained including, without limitation: (a) Debtor’s obligation to keep the Collateral free and clear of all liens, claims, security interest, and other encumbrances; (b) Debtor’s duty to repair, maintain, and preserve the Collateral; and (c) Debtor’s duty to insure the Collateral in accordance with this Agreement, Secured Party may, but shall not be required to, perform such duties and obligations on behalf of Debtor, whereupon Debtor shall promptly reimburse Secured Party for any and all amounts, costs, and/or expenses which may be incurred by Secured Party to accomplish the same, plus interest on such amounts at the maximum rate permitted by law, from the date Secured Party pays or incurs the same until paid in full.
5. Events of Default.
The occurrence of any one (1) or more of the following events or conditions shall constitute an event of default hereunder:
(a) Debtor’s failure to pay or perform any indebtedness or obligation contained within the Obligations, when and as the same may be due and performable, after the expiration of any applicable cure or grace period, if any;
(b) Debtor’s breach or violation of any representation, covenant, or warranty herein contained;
(e) the loss, theft, destruction, substantial damage, sale, or encumbrance of the Collateral;
(f) Debtor’s becoming insolvent or generally not paying its debts as such debts become due; or
(g) the making of any general assignment by Debtor for the benefit of creditors; the appointment of a receiver or similar trustee for Debtor or its assets;
(h) if Debtor commences, or has commenced against it (and if such petition or action which is filed against it and such petition or action is not dismissed or stayed within forty-five (45) days), any proceeding or request for relief under any bankruptcy, insolvency or similar laws now or hereafter in effect in the United States of America or any state or territory thereof or any formal or informal proceeding for the dissolution or liquidation of, settlement of claims against or winding up of affairs of Debtor;
| 3 |
(i) any reorganization, merger, consolidation or dissolution of Debtor (or the making of any agreement therefor); the sale, assignment, transfer or delivery of all or substantially all of the assets of Debtor to a third party (other than the Secured Party); or of a majority of the membership interest of Debtor or the cessation by Debtor as a going business concern, including the cessation of the use of its website for more than five (5) consecutive days; or
(j) Any other event set forth as a “Default” under Section 4 of the Note, independently of whether the same shall have been referenced hereinabove.
6. Remedies.
Upon the occurrence of any of the aforementioned Events of Default, and at any time thereafter, Secured Party may declare the Obligations to be immediately due, payable, and performable, whereupon Secured Party may take such actions as it may consider necessary and/or advisable to enforce payment or performance of the same, shall have all of the rights and privileges of a Secured Party under the Uniform Commercial Code as adopted in the State of Delaware, and may exercise such other rights and privileges as may then be available. Without limiting the generality of the foregoing, Secured Party may require Debtor to assemble the Collateral and make it available to Secured Party at any place designated by Secured Party. Unless the Collateral is perishable, threatens to decline significantly in value, or is of a type or category which is customarily sold in a recognized market, Secured Party will give Debtor reasonable notice of the time and place of any public sale or disposition of the Collateral or the time and place after which any private sale of the Collateral may be made. The requirement of providing reasonable notice to Debtor shall be deemed satisfied if any such notice is delivered to Debtor at least five (5) days prior to the date on which any such disposition of the Collateral is to occur, which notice shall be delivered in accordance with Paragraph 9 of this Agreement. All costs and expenses which are expended or incurred by Secured Party to retake, hold, prepare for disposition and/or dispose of the Collateral including, without limitation, attorneys’ fees and legal expenses, shall be added to the indebtedness secured hereby and shall be paid by Debtor to Secured Party.
7. Financing Statements.
The Secured Party is hereby authorized to file all such financing statements as it deems necessary or advisable to secure the security interest granted hereunder, including all renewals and extensions thereof, including any filings with the U.S. Patent and Trademark Office.
8. Waiver.
No failure by Secured Party to insist upon exact compliance with any of the terms, provisions and/or conditions of this Agreement shall be deemed or construed as a waiver of the right to require exact compliance with each and every duty and obligation herein contained in the future.
| 4 |
9. Notices.
All notices, requests or other communications required hereunder shall be in writing and shall be deemed to have been duly given or made if delivered personally or by courier service which obtains a signed receipt upon delivery, or if mailed, by United States certified mail, postage prepaid, return receipt requested, to the parties at the respective addresses first above written, or at such other addresses as shall be specified in writing by either of the parties to the other in accordance with the terms and conditions of this Section. Notices shall be deemed effective, if delivered personally or by courier service, on the date personally delivered or, if mailed in accordance herewith, then three (3) business days after mailing.
10. Assignment by Debtor Prohibited.
Neither this Agreement, nor the duties and obligations evidenced hereby, may be transferred, conveyed, assigned, or otherwise delegated by Debtor without the prior written consent of Secured Party in each instance. Any such actual or attempted transfer, conveyance, assignment, or delegation shall be null, void, and of no legal force or effect, shall convey no rights or benefits to the purported transferee, shall release Debtor from no duty or obligation hereunder, and shall be a material breach of this Agreement.
11. Binding Effect.
This Agreement shall inure to the benefit of, and remain fully binding upon, the parties hereto and their respective successors, survivors and permitted assigns.
12. Governing Law, Jurisdiction and Venue.
THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED AND ENFORCED IN ALL RESPECTS IN ACCORDANCE WITH THE LAWS OF THE STATE OF SOUTH DAKOTA, WITHOUT GIVING EFFECT TO THE PRINCIPALS OR CONFLICTS OF LAW. THE PARTIES HERETO CONSENT THAT ANY LEGAL OR EQUITY PROCEEDING BROUGHT IN CONNECTION WITH OR ARISING OUT OF ANY MATTER RELATING TO THIS AGREEMENT, AND THE TRANSACTIONS TO WHICH IT RELATES, SHALL BE INSTITUTED ONLY IN A FEDERAL OR STATE COURT OF COMPETENT JURISDICTION WITHIN THE STATE AND COUNTY WITHIN WHICH THE PRINCIPAL OFFICES OF THE SECURED PARTY SHALL BE LOCATED ON THE DATE THAT ANY SUCH PROCEEDING IS COMMENCED. THE DEBTOR HEREBY IRREVOCABLY CONSENTS AND SUBMITS TO THE JURISDICTION, IN ANY SUCH MATTER, OF THE COURTS OF SUCH STATE AND COUNTY AND WAIVES ANY OBJECTION DEBTOR MAY HAVE TO EITHER THE JURISDICTION OR VENUE OF SUCH COURTS. THE DEBTOR FURTHER CONSENTS AND AGREES, WITHOUT LIMITING ANY OTHER METHOD OF OBTAINING JURISDICTION, THAT IN ANY ACTION OR PROCEEDING COMMENCED UNDER THE TERMS OF THIS AGREEMENT, SERVICE OF A SUMMONS AND COMPLAINT, OR ANY OTHER PROCESS, IN ANY ACTION OR PROCEEDING, SHALL BE SUFFICIENT IF MADE ON THE DEBTOR BY REGISTERED OR CERTIFIED MAIL TO THE DEBTOR AT THE LAST KNOWN ADDRESS OF THE DEBTOR, WHETHER SUCH ADDRESS SHALL BE WITHIN OR WITHOUT THE JURISDICTION OF THE COURT WHERE SUCH ACTION OR PROCEEDING IS PENDING, AND DEBTOR HEREBY UNCONDITIONALLY AND IRREVOCABLY WAIVES PERSONAL SERVICE OF SUCH PROCESS.
13. Entire Agreement.
This Agreement sets forth the full and complete understanding between Debtor and Secured Party with respect to the terms and conditions under which Debtor will grant Secured Party a security interest in the Collateral as security for the Obligations.
IN WITNESS WHEREOF, Debtor has executed this Agreement as of the day and year first above written.
| DEBTOR: | ||
| PRIME DELTA CORP. | ||
| By: | ||
| Name: | ||
| Title: | ||
| SECURED PARTY: | ||
| AI FINANCIAL CORPORATION | ||
| By: | ||
| Name: | Tony Isaac | |
| Title: | Chief Executive Officer | |
| 5 |
Exhibit 10.130
GUARANTY
THIS GUARANTY (this “Guaranty”), dated July 28, 2026, is made by Jean Francois Amyot, a resident of Mont-Tremblant, Quebec Canada (the “Guarantor”), in favor of AI Financial Corporation, a Nevada corporation (the “Holder”). All initially capitalized terms not defined herein shall have the meaning ascribed in the Note.
W I T N E S S E T H:
WHEREAS, on even date hereof, Prime Delta Corp., a Delaware corporation (the “Maker”) entered into that certain Secured Promissory Note (the “Note”), in favor of Holder, in the amount of $12,000,000.00; and
WHEREAS, it is a condition for Holder accepting the Note that Guarantor shall execute and deliver this Guaranty.
NOW, THEREFORE, in consideration of the premises and to induce Holder to accept the Note, Guarantor hereby agrees as follows:
SECTION 1. Guaranty. Guarantor hereby unconditionally, absolutely, and irrevocably guarantees the payment and performance of the obligations of the Maker set forth in the Note (the “Guaranteed Obligations”). Guarantor hereby waives any rights of set-off against, defense to, or reduction of, the Guaranteed Obligations based upon any claim Guarantor may have against any other individual or entity. It shall not be necessary for the Holder (and Guarantor hereby waives any rights which Guarantor may have to require the Holder), in order to enforce the obligations of Guarantor hereunder, first to (i) institute suit or exhaust its remedies against any other any individual or entity, (ii) join any other individual or person in any action seeking to enforce the Note, or (iii) resort to any other means of obtaining payment of the Guaranteed Obligations. The Holder shall not be required to take any action to reduce, collect, or enforce the Guaranteed Obligations. Guarantor waives notice of (a) acceptance of the Note, (b) any amendment or modification of the Note, (c) protest, proof of non-payment, or default by the Maker, (d) any other action at any time taken or omitted by the Holder, and, generally, all demands and notices of every kind, (e) the benefit of any statute of limitations which may affect its liability hereunder or the enforcement hereof and any payment by Maker or other circumstance that operates to toll any statute of limitations as to Maker shall operate to toll the statute of limitations as to Guarantor, and (f) all suretyship defenses Guarantor has or would have under the laws of any jurisdiction. Guarantor agrees to each of the following, and agrees that its obligations under this Guaranty shall not be released, diminished, impaired, reduced, or adversely affected by any of the following, and waives any common law, equitable, statutory, or other rights (including without limitation rights to notice) which Guarantor might otherwise have as a result of or in connection with (1) any renewal, extension, increase, modification, alteration, or rearrangement of all or any part of the Guaranteed Obligations or the Note; (2) any insolvency, bankruptcy, arrangement, adjustment, composition, liquidation, disability, dissolution, asset sale, or transfer or change of structure or organization of Maker, (3) the invalidity, illegality, or unenforceability of all or any part of the Guaranteed Obligations or the Note, (4) any full or partial release of the liability of the Maker or any part thereof, or (5) any other action taken or omitted to be taken with respect to the Note, whether or not such action or omission prejudices Guarantor or increases the likelihood that Guarantor will be required to pay the Guaranteed Obligations pursuant to the terms hereof. It is the intention of Guarantor that it shall be obligated to pay the Guaranteed Obligations when due, notwithstanding any occurrence, circumstance, event, action, or omission whatsoever, whether contemplated or not contemplated, and whether or not otherwise or particularly described herein. The guaranty set forth in this Guaranty is an irrevocable, absolute, and continuing guaranty, and it will not be discharged until, and will remain in full force and effect until, payment in full of the amounts required to be paid the Holder as provided for in the Note. This Guaranty may not be revoked by Guarantor and shall continue to be effective with respect to the Guaranteed Obligations arising or created after any attempted revocation by Guarantor. It is the intent of Guarantor and Holder that the obligations and liabilities of Guarantor hereunder are absolute and unconditional under any and all circumstances and that until the Guaranteed Obligations are fully and finally satisfied or there is no continuing liability or obligations of Maker under the Note, such obligations and liabilities of Guarantor shall not be discharged or released in whole or in part, by any act or occurrence which might, but for the provisions of this Guaranty, be deemed a legal or equitable discharge or release of Guarantor.
SECTION 2. This Guaranty shall continue to be effective or be reinstated, as the case may be, if at any time payment or any part of the Note, or the obligations represented thereby, is rescinded, held to constitute a preference under applicable bankruptcy laws, or must otherwise be restored, refunded, or returned by Holder upon the insolvency, bankruptcy, dissolution, liquidation, or the reorganization of Maker, or upon or as a result of the appointment of a receiver, intervenor, custodian, or conservator of, or trustee or similar officer for, Maker or any substantial part of its property, or otherwise, all as though such payments had not been made.
SECTION 3. If the Guaranteed Obligations, or any part thereof, are not punctually paid, Guarantor shall, within three (3) calendar days after written demand and without protest or notice of protest, pay the amount due thereon to Holder at its address set forth below or as otherwise designated by Holder. Such demand(s) may be made at any time coincident with or after the time for payment of all or part of the Guaranteed Obligations. Such demand shall be deemed made and given in accordance with Section 10 below. Except as may be required by applicable law, it shall not be necessary for Holder, in order to enforce such payment or performance by Guarantor, first to institute suit or exhaust its remedies against Maker or others actually, potentially, or contingently liable to pay or perform such Guaranteed Obligations. Except to the extent required by applicable law, Holder shall not be required to mitigate damages or take any other action to reduce, collect or enforce the Note or Guaranteed Obligations. No set-off, counterclaim (other than compulsory counterclaims), reduction, or diminution of any obligations, or any defense of any kind or nature which Guarantor has or may hereafter have against Maker or Holder shall be available hereunder to Guarantor.
SECTION 4. Amendments; Waiver. No amendment or waiver of any provision of this Guaranty, nor consent to any departure by Guarantor therefrom, shall in any event be effective unless the same shall be in writing and signed by Guarantor and the Holder, and then such waiver or consent shall be effective only in the specific instance and for the specific purpose for which given.
SECTION 5. Governing Law, Jurisdiction and Jury Trial. This Guaranty will be governed by and construed in accordance with the laws of the State of New York applicable to contracts made and to be performed entirely within such State. The parties hereby irrevocably and unconditionally consent to submit to the exclusive jurisdiction of the state and federal courts located in the State of Nevada for any actions, suits, or proceedings arising out of or relating to this Guaranty and the transactions contemplated hereby. Guarantor irrevocably submits to the nonexclusive personal jurisdiction of such courts. To the maximum extent permitted, Guarantor and Holder waive the right to a jury trial in connection with any action, suit, or proceeding (including any and all counterclaims thereto) that directly or indirectly relates to the subject matter of this Guaranty.
SECTION 6. Defined Terms. Capitalized terms not otherwise defined herein shall have the same meanings as specified therefor in the Note.
SECTION 7. Successors and Assigns; Benefit. This Guaranty shall be binding upon Guarantor and its successors, assigns, members, and legal representatives and shall not be discharged in whole or in part by the dissolution of Guarantor. Guarantor may not delegate or assign any of its duties, obligations or liability under this Guaranty without the prior written consent of Holder. This Guaranty is for the benefit of Holder and its successors and assigns, and, in the event of an assignment by Holder or its respective successors or assigns of their interest in the Note, or any part thereof, in accordance with the provisions of the Note, the rights and benefits hereunder, to the extent applicable to the rights so assigned, may be transferred with such rights.
SECTION 8. No Waiver; Remedies. No failure on the part of Holder to exercise, and no delay in exercising, any right hereunder shall operate as a waiver thereof; nor shall any single or partial exercise of any right hereunder preclude any other or further exercise thereof or the exercise of any other right. All remedies afforded to Holder by reason of this Guaranty and the Note are separate and cumulative remedies and each one of such remedies, whether exercised by Holder or not, shall not be deemed to be exclusive of any of the other remedies available to Holder and shall not limit or prejudice any other legal or equitable remedy which Holder may have under this Guaranty or the Note.
SECTION 9. Representations and Warranties: Guarantor represents and warrants to Holder, as of the date hereof, as follows:
(a) Guarantor has full power, authority and legal right to execute and deliver this Guaranty and perform fully and completely all of its obligations hereunder;
(b) Guarantor has received, or will receive, direct or indirect benefit from the making of this Guaranty and the making of the Loan to Maker by Holder;
(c) Neither Holder nor any agent, representative, or employee of Holder has made any representation, warranty, or statement to Guarantor in order to induce Guarantor to execute this Guaranty;
(d) After giving effect to this Guaranty and the contingent obligations evidenced hereby, Guarantor is, and will be, solvent, and has and will have assets, which, fairly valued, exceed their respective obligations, liabilities, and debts, and has and will have property and assets sufficient to satisfy and repay its obligations and liabilities; and
(e) Neither the execution and delivery of this Guaranty nor the consummation of the transactions herein contemplated, nor compliance with the terms and provisions hereof, will contravene any provision of applicable law, statute, rule, or regulation or any judgment, decree, franchise, order, or permit applicable to Guarantor or will conflict or be inconsistent with, or will result in any breach of, any of the terms, covenants, conditions, or provisions of, or constitute a default under, the terms of any indenture, mortgage, deed of trust, agreement, or other instruments to which Guarantor is a party or by which Guarantor or any of its property may be bound.
SECTION 10. Notice. Any notice, request, instruction or other document to be given hereunder by any party to the other will be in writing and will be deemed to have been duly given (a) on the date of delivery or refusal of delivery if delivered personally or by facsimile, upon confirmation of receipt, (b) on the first business day following the date of dispatch if delivered by a recognized next-day courier service, or (c) on the third business day following the date of mailing if delivered by registered or certified mail, return receipt requested and postage prepaid. All notices hereunder shall be delivered as set forth below, or pursuant to such other instructions as may be designate in writing by the party to receive such notice.
If to Guarantor:
Jean Francois Amyot
315 Chemin Claude Lefebvre
Mont-Tremblant, Quebec Canada
E-mail: jfamyot@gmail.com
If to Holder:
AI Financial Corporation
8548 Rozita Lee Avenue, Suite 305
Las Vegas, Nevada 89113
Attn: Tony Isaac
E-mail: t.isaac@isaac.com
SECTION 11. Joint and Several Obligation. All obligations hereunder of the individuals comprising the Guarantor are joint and several.
IN WITNESS WHEREOF, Guarantor has caused this Guaranty to be duly executed as of the date first above written.
| Jean Francois Amyot |
State of ; County of ss.:
On July _____ , 2026 before me, the undersigned, personally appeared Jean Francois Amyot, personally known to me or proved to me on the basis of satisfactory evidence to be the individual whose name is subscribed to the within instrument and acknowledged to me that he executed the same in his capacity, and that by his signature on the instrument, the individual, or the person upon behalf of which the individual acted, executed the instrument.
| Notary Public |
Exhibit 10.131
GUARANTY
THIS GUARANTY (this “Guaranty”), dated July 28, 2026, is made by Jason Lake, trustee of the Wellington Peel Trust, U/D/T March 25, 2016, a trust formed under Delaware law (the “Guarantor”), in favor of AI Financial Corporation, a Nevada corporation (the “Holder”). All initially capitalized terms not defined herein shall have the meaning ascribed in the Note.
W I T N E S S E T H:
WHEREAS, on even date hereof, Prime Delta Corp., a Delaware corporation (the “Maker”) entered into that certain Secured Promissory Note (the “Note”), in favor of Holder, in the amount of $12,000,000.00; and
WHEREAS, it is a condition for Holder accepting the Note that Guarantor shall execute and deliver this Guaranty.
NOW, THEREFORE, in consideration of the premises and to induce Holder to accept the Note, Guarantor hereby agrees as follows:
SECTION 1. Guaranty. Guarantor hereby unconditionally, absolutely, and irrevocably guarantees the payment and performance of the obligations of the Maker set forth in the Note (the “Guaranteed Obligations”). Guarantor hereby waives any rights of set-off against, defense to, or reduction of, the Guaranteed Obligations based upon any claim Guarantor may have against any other individual or entity. It shall not be necessary for the Holder (and Guarantor hereby waives any rights which Guarantor may have to require the Holder), in order to enforce the obligations of Guarantor hereunder, first to (i) institute suit or exhaust its remedies against any other any individual or entity, (ii) join any other individual or person in any action seeking to enforce the Note, or (iii) resort to any other means of obtaining payment of the Guaranteed Obligations. The Holder shall not be required to take any action to reduce, collect, or enforce the Guaranteed Obligations. Guarantor waives notice of (a) acceptance of the Note, (b) any amendment or modification of the Note, (c) protest, proof of non-payment, or default by the Maker, (d) any other action at any time taken or omitted by the Holder, and, generally, all demands and notices of every kind, (e) the benefit of any statute of limitations which may affect its liability hereunder or the enforcement hereof and any payment by Maker or other circumstance that operates to toll any statute of limitations as to Maker shall operate to toll the statute of limitations as to Guarantor, and (f) all suretyship defenses Guarantor has or would have under the laws of any jurisdiction. Guarantor agrees to each of the following, and agrees that its obligations under this Guaranty shall not be released, diminished, impaired, reduced, or adversely affected by any of the following, and waives any common law, equitable, statutory, or other rights (including without limitation rights to notice) which Guarantor might otherwise have as a result of or in connection with (1) any renewal, extension, increase, modification, alteration, or rearrangement of all or any part of the Guaranteed Obligations or the Note; (2) any insolvency, bankruptcy, arrangement, adjustment, composition, liquidation, disability, dissolution, asset sale, or transfer or change of structure or organization of Maker, (3) the invalidity, illegality, or unenforceability of all or any part of the Guaranteed Obligations or the Note, (4) any full or partial release of the liability of the Maker or any part thereof, or (5) any other action taken or omitted to be taken with respect to the Note, whether or not such action or omission prejudices Guarantor or increases the likelihood that Guarantor will be required to pay the Guaranteed Obligations pursuant to the terms hereof. It is the intention of Guarantor that it shall be obligated to pay the Guaranteed Obligations when due, notwithstanding any occurrence, circumstance, event, action, or omission whatsoever, whether contemplated or not contemplated, and whether or not otherwise or particularly described herein. The guaranty set forth in this Guaranty is an irrevocable, absolute, and continuing guaranty, and it will not be discharged until, and will remain in full force and effect until, payment in full of the amounts required to be paid the Holder as provided for in the Note. This Guaranty may not be revoked by Guarantor and shall continue to be effective with respect to the Guaranteed Obligations arising or created after any attempted revocation by Guarantor. It is the intent of Guarantor and Holder that the obligations and liabilities of Guarantor hereunder are absolute and unconditional under any and all circumstances and that until the Guaranteed Obligations are fully and finally satisfied or there is no continuing liability or obligations of Maker under the Note, such obligations and liabilities of Guarantor shall not be discharged or released in whole or in part, by any act or occurrence which might, but for the provisions of this Guaranty, be deemed a legal or equitable discharge or release of Guarantor.
SECTION 2. This Guaranty shall continue to be effective or be reinstated, as the case may be, if at any time payment or any part of the Note, or the obligations represented thereby, is rescinded, held to constitute a preference under applicable bankruptcy laws, or must otherwise be restored, refunded, or returned by Holder upon the insolvency, bankruptcy, dissolution, liquidation, or the reorganization of Maker, or upon or as a result of the appointment of a receiver, intervenor, custodian, or conservator of, or trustee or similar officer for, Maker or any substantial part of its property, or otherwise, all as though such payments had not been made.
SECTION 3. If the Guaranteed Obligations, or any part thereof, are not punctually paid, Guarantor shall, within three (3) calendar days after written demand and without protest or notice of protest, pay the amount due thereon to Holder at its address set forth below or as otherwise designated by Holder. Such demand(s) may be made at any time coincident with or after the time for payment of all or part of the Guaranteed Obligations. Such demand shall be deemed made and given in accordance with Section 10 below. Except as may be required by applicable law, it shall not be necessary for Holder, in order to enforce such payment or performance by Guarantor, first to institute suit or exhaust its remedies against Maker or others actually, potentially, or contingently liable to pay or perform such Guaranteed Obligations. Except to the extent required by applicable law, Holder shall not be required to mitigate damages or take any other action to reduce, collect or enforce the Note or Guaranteed Obligations. No set-off, counterclaim (other than compulsory counterclaims), reduction, or diminution of any obligations, or any defense of any kind or nature which Guarantor has or may hereafter have against Maker or Holder shall be available hereunder to Guarantor.
SECTION 4. Amendments; Waiver. No amendment or waiver of any provision of this Guaranty, nor consent to any departure by Guarantor therefrom, shall in any event be effective unless the same shall be in writing and signed by Guarantor and the Holder, and then such waiver or consent shall be effective only in the specific instance and for the specific purpose for which given.
SECTION 5. Governing Law, Jurisdiction and Jury Trial. This Guaranty will be governed by and construed in accordance with the laws of the State of New York applicable to contracts made and to be performed entirely within such State. The parties hereby irrevocably and unconditionally consent to submit to the exclusive jurisdiction of the state and federal courts located in the State of Nevada for any actions, suits, or proceedings arising out of or relating to this Guaranty and the transactions contemplated hereby. Guarantor irrevocably submits to the nonexclusive personal jurisdiction of such courts. To the maximum extent permitted, Guarantor and Holder waive the right to a jury trial in connection with any action, suit, or proceeding (including any and all counterclaims thereto) that directly or indirectly relates to the subject matter of this Guaranty.
SECTION 6. Defined Terms. Capitalized terms not otherwise defined herein shall have the same meanings as specified therefor in the Note.
SECTION 7. Successors and Assigns; Benefit. This Guaranty shall be binding upon Guarantor and its successors, assigns, members, and legal representatives and shall not be discharged in whole or in part by the dissolution of Guarantor. Guarantor may not delegate or assign any of its duties, obligations or liability under this Guaranty without the prior written consent of Holder. This Guaranty is for the benefit of Holder and its successors and assigns, and, in the event of an assignment by Holder or its respective successors or assigns of their interest in the Note, or any part thereof, in accordance with the provisions of the Note, the rights and benefits hereunder, to the extent applicable to the rights so assigned, may be transferred with such rights.
SECTION 8. No Waiver; Remedies. No failure on the part of Holder to exercise, and no delay in exercising, any right hereunder shall operate as a waiver thereof; nor shall any single or partial exercise of any right hereunder preclude any other or further exercise thereof or the exercise of any other right. All remedies afforded to Holder by reason of this Guaranty and the Note are separate and cumulative remedies and each one of such remedies, whether exercised by Holder or not, shall not be deemed to be exclusive of any of the other remedies available to Holder and shall not limit or prejudice any other legal or equitable remedy which Holder may have under this Guaranty or the Note.
SECTION 9. Representations and Warranties: Guarantor represents and warrants to Holder, as of the date hereof, as follows:
(a) Guarantor has full power, authority and legal right to execute and deliver this Guaranty and perform fully and completely all of its obligations hereunder;
(b) Guarantor has received, or will receive, direct or indirect benefit from the making of this Guaranty and the making of the Loan to Maker by Holder;
(c) Neither Holder nor any agent, representative, or employee of Holder has made any representation, warranty, or statement to Guarantor in order to induce Guarantor to execute this Guaranty;
(d) After giving effect to this Guaranty and the contingent obligations evidenced hereby, Guarantor is, and will be, solvent, and has and will have assets, which, fairly valued, exceed their respective obligations, liabilities, and debts, and has and will have property and assets sufficient to satisfy and repay its obligations and liabilities; and
(e) Neither the execution and delivery of this Guaranty nor the consummation of the transactions herein contemplated, nor compliance with the terms and provisions hereof, will contravene any provision of applicable law, statute, rule, or regulation or any judgment, decree, franchise, order, or permit applicable to Guarantor or will conflict or be inconsistent with, or will result in any breach of, any of the terms, covenants, conditions, or provisions of, or constitute a default under, the terms of any indenture, mortgage, deed of trust, agreement, or other instruments to which Guarantor is a party or by which Guarantor or any of its property may be bound.
SECTION 10. Notice. Any notice, request, instruction or other document to be given hereunder by any party to the other will be in writing and will be deemed to have been duly given (a) on the date of delivery or refusal of delivery if delivered personally or by facsimile, upon confirmation of receipt, (b) on the first business day following the date of dispatch if delivered by a recognized next-day courier service, or (c) on the third business day following the date of mailing if delivered by registered or certified mail, return receipt requested and postage prepaid. All notices hereunder shall be delivered as set forth below, or pursuant to such other instructions as may be designate in writing by the party to receive such notice.
If to Guarantor:
Jason Lake trustee of the Wellington Peel Trust U/D/T [date*]
18 Pods Lane, Oro Medonte
ON, LOL 2LO
Attn: Jason Lake, Trustee
E-mail: jason.lake@primedelta.io
If to Holder:
AI Financial Corporation
8548 Rozita Lee Avenue, Suite 305
Las Vegas, Nevada 89113
Attn: Tony Isaac
E-mail: t.isaac@isaac.com
SECTION 11. Joint and Several Obligation. All obligations hereunder of the individuals comprising the Guarantor are joint and several.
IN WITNESS WHEREOF, Guarantor has caused this Guaranty to be duly executed as of the date first above written.
| WELLINGTON PEEL TRUST | ||
| By: | ||
| Name: | Jason Lake | |
| Title: | Trustee | |
State of ; County of ss.:
On the ____ day of July, 2026, before me personally came Jason Lake, to me known, who, being by me duly sworn, did depose and say that he is the Trustee of Wellington Peel Trust, a trust formed under Delaware law, described in and which executed the foregoing instrument; and that he executed the foregoing instrument on behalf of said limited liability company, being duly authorized to do so.
| Notary Public |
Exhibit 10.132
GUARANTY
THIS GUARANTY (this “Guaranty”), dated July 28, 2026, is made by Wellington Peel, LLC, a Delaware limited liability company (the “Guarantor”), in favor of AI Financial Corporation, a Nevada corporation (the “Holder”). All initially capitalized terms not defined herein shall have the meaning ascribed in the Note.
W I T N E S S E T H:
WHEREAS, on even date hereof, Prime Delta Corp., a Delaware corporation (the “Maker”) entered into that certain Secured Promissory Note (the “Note”), in favor of Holder, in the amount of $12,000,000.00; and
WHEREAS, it is a condition for Holder accepting the Note that Guarantor shall execute and deliver this Guaranty.
NOW, THEREFORE, in consideration of the premises and to induce Holder to accept the Note, Guarantor hereby agrees as follows:
SECTION 1. Guaranty. Guarantor hereby unconditionally, absolutely, and irrevocably guarantees the payment and performance of the obligations of the Maker set forth in the Note (the “Guaranteed Obligations”). Guarantor hereby waives any rights of set-off against, defense to, or reduction of, the Guaranteed Obligations based upon any claim Guarantor may have against any other individual or entity. It shall not be necessary for the Holder (and Guarantor hereby waives any rights which Guarantor may have to require the Holder), in order to enforce the obligations of Guarantor hereunder, first to (i) institute suit or exhaust its remedies against any other any individual or entity, (ii) join any other individual or person in any action seeking to enforce the Note, or (iii) resort to any other means of obtaining payment of the Guaranteed Obligations. The Holder shall not be required to take any action to reduce, collect, or enforce the Guaranteed Obligations. Guarantor waives notice of (a) acceptance of the Note, (b) any amendment or modification of the Note, (c) protest, proof of non-payment, or default by the Maker, (d) any other action at any time taken or omitted by the Holder, and, generally, all demands and notices of every kind, (e) the benefit of any statute of limitations which may affect its liability hereunder or the enforcement hereof and any payment by Maker or other circumstance that operates to toll any statute of limitations as to Maker shall operate to toll the statute of limitations as to Guarantor, and (f) all suretyship defenses Guarantor has or would have under the laws of any jurisdiction. Guarantor agrees to each of the following, and agrees that its obligations under this Guaranty shall not be released, diminished, impaired, reduced, or adversely affected by any of the following, and waives any common law, equitable, statutory, or other rights (including without limitation rights to notice) which Guarantor might otherwise have as a result of or in connection with (1) any renewal, extension, increase, modification, alteration, or rearrangement of all or any part of the Guaranteed Obligations or the Note; (2) any insolvency, bankruptcy, arrangement, adjustment, composition, liquidation, disability, dissolution, asset sale, or transfer or change of structure or organization of Maker, (3) the invalidity, illegality, or unenforceability of all or any part of the Guaranteed Obligations or the Note, (4) any full or partial release of the liability of the Maker or any part thereof, or (5) any other action taken or omitted to be taken with respect to the Note, whether or not such action or omission prejudices Guarantor or increases the likelihood that Guarantor will be required to pay the Guaranteed Obligations pursuant to the terms hereof. It is the intention of Guarantor that it shall be obligated to pay the Guaranteed Obligations when due, notwithstanding any occurrence, circumstance, event, action, or omission whatsoever, whether contemplated or not contemplated, and whether or not otherwise or particularly described herein. The guaranty set forth in this Guaranty is an irrevocable, absolute, and continuing guaranty, and it will not be discharged until, and will remain in full force and effect until, payment in full of the amounts required to be paid the Holder as provided for in the Note. This Guaranty may not be revoked by Guarantor and shall continue to be effective with respect to the Guaranteed Obligations arising or created after any attempted revocation by Guarantor. It is the intent of Guarantor and Holder that the obligations and liabilities of Guarantor hereunder are absolute and unconditional under any and all circumstances and that until the Guaranteed Obligations are fully and finally satisfied or there is no continuing liability or obligations of Maker under the Note, such obligations and liabilities of Guarantor shall not be discharged or released in whole or in part, by any act or occurrence which might, but for the provisions of this Guaranty, be deemed a legal or equitable discharge or release of Guarantor.
SECTION 2. This Guaranty shall continue to be effective or be reinstated, as the case may be, if at any time payment or any part of the Note, or the obligations represented thereby, is rescinded, held to constitute a preference under applicable bankruptcy laws, or must otherwise be restored, refunded, or returned by Holder upon the insolvency, bankruptcy, dissolution, liquidation, or the reorganization of Maker, or upon or as a result of the appointment of a receiver, intervenor, custodian, or conservator of, or trustee or similar officer for, Maker or any substantial part of its property, or otherwise, all as though such payments had not been made.
SECTION 3. If the Guaranteed Obligations, or any part thereof, are not punctually paid, Guarantor shall, within three (3) calendar days after written demand and without protest or notice of protest, pay the amount due thereon to Holder at its address set forth below or as otherwise designated by Holder. Such demand(s) may be made at any time coincident with or after the time for payment of all or part of the Guaranteed Obligations. Such demand shall be deemed made and given in accordance with Section 10 below. Except as may be required by applicable law, it shall not be necessary for Holder, in order to enforce such payment or performance by Guarantor, first to institute suit or exhaust its remedies against Maker or others actually, potentially, or contingently liable to pay or perform such Guaranteed Obligations. Except to the extent required by applicable law, Holder shall not be required to mitigate damages or take any other action to reduce, collect or enforce the Note or Guaranteed Obligations. No set-off, counterclaim (other than compulsory counterclaims), reduction, or diminution of any obligations, or any defense of any kind or nature which Guarantor has or may hereafter have against Maker or Holder shall be available hereunder to Guarantor.
SECTION 4. Amendments; Waiver. No amendment or waiver of any provision of this Guaranty, nor consent to any departure by Guarantor therefrom, shall in any event be effective unless the same shall be in writing and signed by Guarantor and the Holder, and then such waiver or consent shall be effective only in the specific instance and for the specific purpose for which given.
SECTION 5. Governing Law, Jurisdiction and Jury Trial. This Guaranty will be governed by and construed in accordance with the laws of the State of New York applicable to contracts made and to be performed entirely within such State. The parties hereby irrevocably and unconditionally consent to submit to the exclusive jurisdiction of the state and federal courts located in the State of Nevada for any actions, suits, or proceedings arising out of or relating to this Guaranty and the transactions contemplated hereby. Guarantor irrevocably submits to the nonexclusive personal jurisdiction of such courts. To the maximum extent permitted, Guarantor and Holder waive the right to a jury trial in connection with any action, suit, or proceeding (including any and all counterclaims thereto) that directly or indirectly relates to the subject matter of this Guaranty.
SECTION 6. Defined Terms. Capitalized terms not otherwise defined herein shall have the same meanings as specified therefor in the Note.
SECTION 7. Successors and Assigns; Benefit. This Guaranty shall be binding upon Guarantor and its successors, assigns, members, and legal representatives and shall not be discharged in whole or in part by the dissolution of Guarantor. Guarantor may not delegate or assign any of its duties, obligations or liability under this Guaranty without the prior written consent of Holder. This Guaranty is for the benefit of Holder and its successors and assigns, and, in the event of an assignment by Holder or its respective successors or assigns of their interest in the Note, or any part thereof, in accordance with the provisions of the Note, the rights and benefits hereunder, to the extent applicable to the rights so assigned, may be transferred with such rights.
SECTION 8. No Waiver; Remedies. No failure on the part of Holder to exercise, and no delay in exercising, any right hereunder shall operate as a waiver thereof; nor shall any single or partial exercise of any right hereunder preclude any other or further exercise thereof or the exercise of any other right. All remedies afforded to Holder by reason of this Guaranty and the Note are separate and cumulative remedies and each one of such remedies, whether exercised by Holder or not, shall not be deemed to be exclusive of any of the other remedies available to Holder and shall not limit or prejudice any other legal or equitable remedy which Holder may have under this Guaranty or the Note.
SECTION 9. Representations and Warranties: Guarantor represents and warrants to Holder, as of the date hereof, as follows:
(a) Guarantor has full power, authority and legal right to execute and deliver this Guaranty and perform fully and completely all of its obligations hereunder;
(b) Guarantor has received, or will receive, direct or indirect benefit from the making of this Guaranty and the making of the Loan to Maker by Holder;
(c) Neither Holder nor any agent, representative, or employee of Holder has made any representation, warranty, or statement to Guarantor in order to induce Guarantor to execute this Guaranty;
(d) After giving effect to this Guaranty and the contingent obligations evidenced hereby, Guarantor is, and will be, solvent, and has and will have assets, which, fairly valued, exceed their respective obligations, liabilities, and debts, and has and will have property and assets sufficient to satisfy and repay its obligations and liabilities; and
(e) Neither the execution and delivery of this Guaranty nor the consummation of the transactions herein contemplated, nor compliance with the terms and provisions hereof, will contravene any provision of applicable law, statute, rule, or regulation or any judgment, decree, franchise, order, or permit applicable to Guarantor or will conflict or be inconsistent with, or will result in any breach of, any of the terms, covenants, conditions, or provisions of, or constitute a default under, the terms of any indenture, mortgage, deed of trust, agreement, or other instruments to which Guarantor is a party or by which Guarantor or any of its property may be bound.
SECTION 10. Notice. Any notice, request, instruction or other document to be given hereunder by any party to the other will be in writing and will be deemed to have been duly given (a) on the date of delivery or refusal of delivery if delivered personally or by facsimile, upon confirmation of receipt, (b) on the first business day following the date of dispatch if delivered by a recognized next-day courier service, or (c) on the third business day following the date of mailing if delivered by registered or certified mail, return receipt requested and postage prepaid. All notices hereunder shall be delivered as set forth below, or pursuant to such other instructions as may be designate in writing by the party to receive such notice.
If to Guarantor:
Wellington Peel, LLC
18 Pods Lane, Oro Medonte
ON, LOL 2LO
Attn: Jason Lake
E-mail: jason.lake@primedelta.io
If to Holder:
AI Financial Corporation
8548 Rozita Lee Avenue, Suite 305
Las Vegas, Nevada 89113
Attn: Tony Isaac
E-mail: t.isaac@isaac.com
SECTION 11. Joint and Several Obligation. All obligations hereunder of the individuals comprising the Guarantor are joint and several.
IN WITNESS WHEREOF, Guarantor has caused this Guaranty to be duly executed as of the date first above written.
| WELLINGTON PEEL, LLC | ||
| By: | ||
| Name: | Jason Lake | |
| Title: | Manager | |
State of ; County of ss.:
On the ____ day of July, 2026, before me personally came Jason Lake, to me known, who, being by me duly sworn, did depose and say that he is the Manager of Wellington Peel, LLC, a Delaware limited liability company described in and which executed the foregoing instrument; and that he executed the foregoing instrument on behalf of said limited liability company, being duly authorized to do so.
| Notary Public |
Exhibit 31.1
CERTIFICATIONS:
I, Tony Isaac, certify that:
| 1. | I have reviewed this Quarterly Report on Form 10-Q of AI Financial Corporation; | |
| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; | |
| 3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of and for the periods presented in this report; | |
| 4. | The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
| a. | designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; | |
| b. | designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; | |
| c. | evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation; and | |
| d. | disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
| 5. | I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
| a. | all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and | |
| b. | any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
| Date: August 17, 2026 | /s/ Tony Isaac |
| Tony Isaac | |
| Chief Executive Officer |
Exhibit 31.2
CERTIFICATIONS:
I, Steven Plumb, certify that:
| 1. | I have reviewed this Quarterly Report on Form 10-Q of AI Financial Corporation; | |
| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; | |
| 3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of and for the periods presented in this report; | |
| 4. | The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
| a. | designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; | |
| b. | designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; | |
| c. | evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation; and | |
| d. | disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
| 5. | I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
| a. | all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and | |
| b. | any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
| Date: August 17, 2026 | /s/ Steven M. Plumb |
| Steven M. Plumb | |
| Chief Financial Officer |
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to 18 U.S.C. §1350 (as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002), the undersigned Chief Executive Officer of AI Financial Corporation (the “Company”) hereby certifies that the Quarterly Report on Form 10-Q of the Company for the period ended June 27, 2026 (the “Report”) fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Date: August 17, 2026 | /s/ Tony Isaac |
| Tony Isaac | |
| Chief Executive Officer |
The certification set forth above is being furnished as an exhibit solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and is not being filed as part of the Report as a separate disclosure document of the Company or the certifying officers.
A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to 18 U.S.C. §1350 (as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002), the undersigned Chief Financial Officer of AI Financial Corporation (the “Company”) hereby certifies that the Quarterly Report on Form 10-Q of the Company for the period ended June 27, 2026 (the “Report”) fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Date: August 17, 2026 | /s/ Steven M. Plumb |
| Steven M. Plumb | |
| Chief Financial Officer |
The certification set forth above is being furnished as an exhibit solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and is not being filed as part of the Report as a separate disclosure document of the Company or the certifying officers.
A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.